<SEC-DOCUMENT>0001178879-20-000002.txt : 20200107
<SEC-HEADER>0001178879-20-000002.hdr.sgml : 20200107
<ACCEPTANCE-DATETIME>20200107070128
ACCESSION NUMBER:		0001178879-20-000002
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20200107
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200107
DATE AS OF CHANGE:		20200107

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMICUS THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001178879
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				200422823
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33497
		FILM NUMBER:		20512073

	BUSINESS ADDRESS:	
		STREET 1:		1 CEDAR BROOK DRIVE
		CITY:			CRANBURY
		STATE:			NJ
		ZIP:			08512
		BUSINESS PHONE:		(609) 662-2000

	MAIL ADDRESS:	
		STREET 1:		1 CEDAR BROOK DRIVE
		CITY:			CRANBURY
		STATE:			NJ
		ZIP:			08512

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMICUS THERAPEUTICS INC
		DATE OF NAME CHANGE:	20020729
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k1720.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!--p:B2AC477C040850B1815FD97FA9A9F167,x:aba01feac8b24ebead2ff8333d6c2afb-->
<!-- Document created using Wdesk  -->
<!-- Copyright 2020 Workiva -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:schedoi-fednote="http://fasb.org/dis/schedoi-fednote/2019-01-31" xmlns:fs-interest="http://fasb.org/dis/fs-interest/2019-01-31" xmlns:sfp-ibo="http://fasb.org/stm/sfp-ibo/2019-01-31" xmlns:sfp-sbo="http://fasb.org/stm/sfp-sbo/2019-01-31" xmlns:sic-std="http://xbrl.sec.gov/sic-std/2011-01-31" xmlns:stpr-std="http://xbrl.sec.gov/stpr-std-std-std/2018-01-31" xmlns:currency-ent-std="http://xbrl.sec.gov/currency-ent-std/2019-01-31" xmlns:lea="http://fasb.org/dis/lea/2019-01-31" xmlns:ctbl="http://fasb.org/dis/ctbl/2019-01-31" xmlns:guar="http://fasb.org/dis/guar/2019-01-31" xmlns:ru="http://fasb.org/dis/ru/2019-01-31" xmlns:stpr-all="http://xbrl.sec.gov/stpr-all-all-all/2018-01-31" xmlns:leas="http://fasb.org/dis/leas/2019-01-31" xmlns:sfp-clreo="http://fasb.org/stm/sfp-clreo/2019-01-31" xmlns:iaoi="http://fasb.org/dis/iaoi/2019-01-31" xmlns:soi-ins="http://fasb.org/stm/soi-ins/2019-01-31" xmlns:country-ent-std="http://xbrl.sec.gov/country-ent-std/2017-01-31" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:fs-insa="http://fasb.org/dis/fs-insa/2019-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:cce="http://fasb.org/dis/cce/2019-01-31" xmlns:inv="http://fasb.org/dis/inv/2019-01-31" xmlns:naics-ent-std="http://xbrl.sec.gov/naics-ent-std/2017-01-31" xmlns:srt-std="http://fasb.org/srt-std/2019-01-31" xmlns:stpr-ent-all="http://xbrl.sec.gov/stpr-ent-all-all-all/2018-01-31" xmlns:stpr-ent-std="http://xbrl.sec.gov/stpr-ent-std-std-std/2018-01-31" xmlns:schedoi-iiaa="http://fasb.org/dis/schedoi-iiaa/2019-01-31" xmlns:us-arcroles="http://fasb.org/us-arcroles/2019-01-31" xmlns:dccpoa="http://fasb.org/dis/dccpoa/2019-01-31" xmlns:soi-sbi="http://fasb.org/stm/soi-sbi/2019-01-31" xmlns:us-gaap-all="http://fasb.org/us-gaap-all/2019-01-31" xmlns:scf-sd="http://fasb.org/stm/scf-sd/2019-01-31" xmlns:ceclcalc3l="http://fasb.org/dis/ceclcalc3l/2019-01-31" xmlns:dei-ent-all="http://xbrl.sec.gov/dei-ent-all/2019-01-31" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:naics-all="http://xbrl.sec.gov/naics-all/2017-01-31" xmlns:re="http://fasb.org/dis/re/2019-01-31" xmlns:srt-types="http://fasb.org/srt-types/2019-01-31" xmlns:reorg="http://fasb.org/dis/reorg/2019-01-31" xmlns:invco="http://fasb.org/dis/invco/2019-01-31" xmlns:currency-ent-all="http://xbrl.sec.gov/currency-ent-all/2019-01-31" xmlns:currency-std="http://xbrl.sec.gov/currency-std/2019-01-31" xmlns:currency-ent-dep="http://xbrl.sec.gov/currency-ent-dep/2019-01-31" xmlns:aro="http://fasb.org/dis/aro/2019-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2019-01-31" xmlns:ocpfs="http://fasb.org/dis/ocpfs/2019-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2019-01-31" xmlns:naics-std="http://xbrl.sec.gov/naics-std/2017-01-31" xmlns:srt-all="http://fasb.org/srt-all/2019-01-31" xmlns:codification-part="http://fasb.org/codification-part/2019-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:deprecated1="http://www.xbrl.org/2009/role/deprecated" xmlns:sec-re="http://fasb.org/dis/sec-re/2019-01-31" xmlns:soi-int="http://fasb.org/stm/soi-int/2019-01-31" xmlns:emjv="http://fasb.org/dis/emjv/2019-01-31" xmlns:sec-suppc="http://fasb.org/dis/sec-suppc/2019-01-31" xmlns:equity="http://fasb.org/dis/equity/2019-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:se="http://fasb.org/dis/se/2019-01-31" xmlns:crcrb="http://fasb.org/dis/crcrb/2019-01-31" xmlns:edco="http://fasb.org/dis/edco/2019-01-31" xmlns:te="http://fasb.org/dis/te/2019-01-31" xmlns:dei-all="http://xbrl.sec.gov/dei-all/2019-01-31" xmlns:fs-bd="http://fasb.org/dis/fs-bd/2019-01-31" xmlns:invest-all="http://xbrl.sec.gov/invest-all/2013-01-31" xmlns:hco="http://fasb.org/dis/hco/2019-01-31" xmlns:fs-bt="http://fasb.org/dis/fs-bt/2019-01-31" xmlns:us-roles="http://fasb.org/us-roles/2019-01-31" xmlns:dr="http://fasb.org/dis/dr/2019-01-31" xmlns:ero="http://fasb.org/dis/ero/2019-01-31" xmlns:country-ent-all="http://xbrl.sec.gov/country-ent-all/2017-01-31" xmlns:schedoi-oocw="http://fasb.org/dis/schedoi-oocw/2019-01-31" xmlns:cecl="http://fasb.org/dis/cecl/2019-01-31" xmlns:rpd="http://fasb.org/dis/rpd/2019-01-31" xmlns:schedoi-sumhold="http://fasb.org/dis/schedoi-sumhold/2019-01-31" xmlns:ceclcalc2="http://fasb.org/dis/ceclcalc2/2019-01-31" xmlns:othliab="http://fasb.org/dis/othliab/2019-01-31" xmlns:soi-egm="http://fasb.org/stm/soi-egm/2019-01-31" xmlns:schedoi-shorthold="http://fasb.org/dis/schedoi-shorthold/2019-01-31" xmlns:soi="http://fasb.org/stm/soi/2019-01-31" xmlns:diha="http://fasb.org/dis/diha/2019-01-31" xmlns:debt="http://fasb.org/dis/debt/2019-01-31" xmlns:schedoi-hold="http://fasb.org/dis/schedoi-hold/2019-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:invest-std="http://xbrl.sec.gov/invest-std/2013-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-gaap-ent-std="http://fasb.org/us-gaap-ent-std/2019-01-31" xmlns:bc="http://fasb.org/dis/bc/2019-01-31" xmlns:sic-ent-all="http://xbrl.sec.gov/sic-ent-all/2011-01-31" xmlns:exch-ent-std="http://xbrl.sec.gov/exch-ent-std/2019-01-31" xmlns:invest-ent-all="http://xbrl.sec.gov/invest-ent-all/2013-01-31" xmlns:rcc="http://fasb.org/dis/rcc/2019-01-31" xmlns:rd="http://fasb.org/dis/rd/2019-01-31" xmlns:sfp-ucreo="http://fasb.org/stm/sfp-ucreo/2019-01-31" xmlns:eui="http://fasb.org/dis/eui/2019-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:ap="http://fasb.org/dis/ap/2019-01-31" xmlns:soi-reit="http://fasb.org/stm/soi-reit/2019-01-31" xmlns:fold="http://www.amicustherapeutics.com/20200107" xmlns:fs-mort="http://fasb.org/dis/fs-mort/2019-01-31" xmlns:sec-reins="http://fasb.org/dis/sec-reins/2019-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:sec-cndfir="http://fasb.org/dis/sec-cndfir/2019-01-31" xmlns:sr="http://fasb.org/dis/sr/2019-01-31" xmlns:currency-all="http://xbrl.sec.gov/currency-all/2019-01-31" xmlns:scf-dbo="http://fasb.org/stm/scf-dbo/2019-01-31" xmlns:fs-fhlb="http://fasb.org/dis/fs-fhlb/2019-01-31" xmlns:crcpb="http://fasb.org/dis/crcpb/2019-01-31" xmlns:dei-ent-std="http://xbrl.sec.gov/dei-ent-std/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:scf-inv="http://fasb.org/stm/scf-inv/2019-01-31" xmlns:scf-indira="http://fasb.org/stm/scf-indira/2019-01-31" xmlns:bsoff="http://fasb.org/dis/bsoff/2019-01-31" xmlns:exch-ent-all="http://xbrl.sec.gov/exch-ent-all/2019-01-31" xmlns:oi="http://fasb.org/dis/oi/2019-01-31" xmlns:soi-indira="http://fasb.org/stm/soi-indira/2019-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:schedoi-otsh="http://fasb.org/dis/schedoi-otsh/2019-01-31" xmlns:sfp-dbo="http://fasb.org/stm/sfp-dbo/2019-01-31" xmlns:cc="http://fasb.org/dis/cc/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:crcsbp="http://fasb.org/dis/crcsbp/2019-01-31" xmlns:disops="http://fasb.org/dis/disops/2019-01-31" xmlns:reference="http://www.xbrl.org/2009/role/reference" xmlns:cn-part="http://fasb.org/cn-part/2019-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:srt-roles="http://fasb.org/srt-roles/2019-01-31" xmlns:country-std="http://xbrl.sec.gov/country-std/2017-01-31" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:scf-indir="http://fasb.org/stm/scf-indir/2019-01-31" xmlns:rlnro="http://fasb.org/dis/rlnro/2019-01-31" xmlns:ts="http://fasb.org/dis/ts/2019-01-31" xmlns:us-gaap-std="http://fasb.org/us-gaap-std/2019-01-31" xmlns:naics-ent-all="http://xbrl.sec.gov/naics-ent-all/2017-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:scf-dir="http://fasb.org/stm/scf-dir/2019-01-31" xmlns:dei-std="http://xbrl.sec.gov/dei-std/2019-01-31" xmlns:ni="http://fasb.org/dis/ni/2019-01-31" xmlns:sec-mort="http://fasb.org/dis/sec-mort/2019-01-31" xmlns:fifvd="http://fasb.org/dis/fifvd/2019-01-31" xmlns:otherexp="http://fasb.org/dis/otherexp/2019-01-31" xmlns:scf-re="http://fasb.org/stm/scf-re/2019-01-31" xmlns:sec-vq="http://fasb.org/dis/sec-vq/2019-01-31" xmlns:sec-sum="http://fasb.org/dis/sec-sum/2019-01-31" xmlns:exch-std="http://xbrl.sec.gov/exch-std/2019-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:ir="http://fasb.org/dis/ir/2019-01-31" xmlns:sheci="http://fasb.org/stm/sheci/2019-01-31" xmlns:foct="http://fasb.org/dis/foct/2019-01-31" xmlns:soc="http://fasb.org/stm/soc/2019-01-31" xmlns:scf-sbo="http://fasb.org/stm/scf-sbo/2019-01-31" xmlns:inctax="http://fasb.org/dis/inctax/2019-01-31" xmlns:ppe="http://fasb.org/dis/ppe/2019-01-31" xmlns:country-all="http://xbrl.sec.gov/country-all/2017-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:con="http://fasb.org/dis/con/2019-01-31" xmlns:sic-ent-std="http://xbrl.sec.gov/sic-ent-std/2011-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:invest-ent-std="http://xbrl.sec.gov/invest-ent-std/2013-01-31" xmlns:fs-ins="http://fasb.org/dis/fs-ins/2019-01-31" xmlns:eps="http://fasb.org/dis/eps/2019-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:iago="http://fasb.org/dis/iago/2019-01-31" xmlns:pay="http://fasb.org/dis/pay/2019-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:tin-part="http://fasb.org/tin-part/2019-01-31" xmlns:acec="http://fasb.org/dis/acec/2019-01-31" xmlns:us-gaap-entryPoint-all="http://fasb.org/us-gaap-entryPoint-all/2019-01-31" xmlns:nt="http://fasb.org/dis/nt/2019-01-31" xmlns:spc="http://fasb.org/stm/spc/2019-01-31" xmlns:exch-all="http://xbrl.sec.gov/exch-all/2019-01-31" xmlns:ides="http://fasb.org/dis/ides/2019-01-31" xmlns:sec-supins="http://fasb.org/dis/sec-supins/2019-01-31" xmlns:sic-all="http://xbrl.sec.gov/sic-all/2011-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:regop="http://fasb.org/dis/regop/2019-01-31" xmlns:sfp-cls="http://fasb.org/stm/sfp-cls/2019-01-31" xmlns:com="http://fasb.org/stm/com/2019-01-31" xmlns:soi-re="http://fasb.org/stm/soi-re/2019-01-31" xmlns:crcgen="http://fasb.org/dis/crcgen/2019-01-31" xmlns:exch-ent-dep="http://xbrl.sec.gov/exch-ent-dep/2019-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:ei="http://fasb.org/dis/ei/2019-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
	<head>
		<meta http-equiv="Content-Type" content="text/html" />
		<title>Document</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="D2020Q1F8K1720" name="dei:AmendmentFlag" id="Fact-5386408C7FE653C8A0275572E7375F66-wk-Fact-5386408C7FE653C8A0275572E7375F66" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric contextRef="D2020Q1F8K1720" name="dei:EntityCentralIndexKey" id="Fact-906BA0321B005F22A71015A6F43DBCCC-wk-Fact-906BA0321B005F22A71015A6F43DBCCC">0001178879</ix:nonNumeric><ix:nonNumeric contextRef="D2020Q1F8K1720" name="dei:WrittenCommunications" id="Fact-5478DFACF8145676800C13AD9B6636CA-wk-Fact-5478DFACF8145676800C13AD9B6636CA" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="fold-20200107.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="D2020Q1F8K1720">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001178879</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-07</xbrli:startDate>
			<xbrli:endDate>2020-01-07</xbrli:endDate>
		</xbrli:period>
	</xbrli:context></ix:resources></ix:header></div><div><a id="s3672D24758625749B47FACF5ED21B7CD"></a></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:232%;padding-bottom:0px;text-align:center;padding-left:37px;text-indent:24px;font-size:18pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span><span style="font-family:inherit;font-size:18pt;font-weight:bold;">UNITED STATES</span></div><div style="line-height:120%;text-align:center;padding-left:34px;text-indent:-2px;font-size:18pt;"><span style="font-family:inherit;font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="line-height:120%;text-align:center;padding-left:36px;text-indent:-2px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">WASHINGTON, D.C. 20549</span></div><div style="line-height:120%;text-align:center;padding-left:34px;text-indent:-2px;font-size:18pt;"><span style="font-family:inherit;font-size:18pt;font-weight:bold;">FORM </span><span><ix:nonNumeric id="d836691e76-wk-Fact-464A019E1AD0571A9184ED7BB6C7BDCF" name="dei:DocumentType" contextRef="D2020Q1F8K1720"><span style="font-size:18pt;font-weight:bold;">8-K</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:18pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:left;padding-left:38px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;padding-left:34px;text-indent:-2px;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;font-weight:bold;">CURRENT REPORT PURSUANT TO</span></div><div style="line-height:120%;text-align:center;padding-left:34px;text-indent:-2px;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;font-weight:bold;">SECTION 13 OR 15(d) OF THE</span></div><div style="line-height:120%;text-align:center;padding-left:34px;text-indent:-2px;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;font-weight:bold;">SECURITIES EXCHANGE ACT OF 1934</span></div><div style="line-height:120%;text-align:left;padding-left:38px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:16px;text-align:center;padding-left:34px;text-indent:-2px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Date of Report (Date of earliest event reported): </span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span><span style="white-space:nowrap"><ix:nonNumeric id="d836691e97-wk-Fact-4BBB31F4023852A489C695FDF09EDD04" name="dei:DocumentPeriodEndDate" contextRef="D2020Q1F8K1720" format="ixt:datemonthdayyearen">January 7, 2020</ix:nonNumeric></span></span></span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;padding-top:8px;text-align:center;padding-left:34px;text-indent:-2px;font-size:18pt;"><span><ix:nonNumeric id="d836691e102-wk-Fact-663DA40863035442A9E7978722C1C0CD" name="dei:EntityRegistrantName" contextRef="D2020Q1F8K1720"><span style="font-size:18pt;font-weight:bold;">AMICUS THERAPEUTICS, INC.</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:18pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:center;padding-left:34px;text-indent:-2px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(Exact Name of Registrant as Specified in Its Charter)</span></div><div style="line-height:120%;text-align:center;padding-left:36px;text-indent:-2px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;padding-left:36px;text-indent:-2px;font-size:10pt;"><span><ix:nonNumeric id="d836691e114-wk-Fact-6600411D963A5E7DA8D39BB61F588CCC" name="dei:EntityIncorporationStateCountryCode" contextRef="D2020Q1F8K1720" format="ixt-sec:stateprovnameen"><span style="font-weight:bold;">Delaware</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:center;padding-left:34px;text-indent:-2px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(State or Other Jurisdiction of</span></div><div style="line-height:120%;text-align:center;padding-left:34px;text-indent:-2px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Incorporation)</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:716px;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:244px;"></td><td style="width:6px;"></td><td style="width:229px;"></td><td style="width:6px;"></td><td style="width:229px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Delaware</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d836691e151-wk-Fact-0270800C74355A7AA030B8F30DB54188" name="dei:EntityFileNumber" contextRef="D2020Q1F8K1720">001-33497</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d836691e161-wk-Fact-E6ADB3ED21CB5529B17A868F8BDF7711" name="dei:EntityTaxIdentificationNumber" contextRef="D2020Q1F8K1720">71-0869350</ix:nonNumeric></span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(State or Other Jurisdiction</span></div><div style="padding-bottom:1px;text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">of Incorporation)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Commission</span></div><div style="padding-bottom:1px;text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">File Number)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(I.R.S. Employer</span></div><div style="padding-bottom:1px;text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Identification No.)</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;text-indent:192px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d836691e205-wk-Fact-25B47E2EF2A05944840D22689EDE895B" name="dei:EntityAddressAddressLine1" contextRef="D2020Q1F8K1720">1 Cedar Brook Drive</ix:nonNumeric></span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d836691e209-wk-Fact-923B760AE05A51C28D45E11C4F4AC37C" name="dei:EntityAddressCityOrTown" contextRef="D2020Q1F8K1720">Cranbury</ix:nonNumeric></span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d836691e213-wk-Fact-03D4C0C965A5557C802E9B5D3DD1AD44" name="dei:EntityAddressStateOrProvince" contextRef="D2020Q1F8K1720">NJ</ix:nonNumeric></span></span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d836691e217-wk-Fact-5BCF5A98466356C6ACABEDE9B238D73F" name="dei:EntityAddressPostalZipCode" contextRef="D2020Q1F8K1720">08512</ix:nonNumeric></span></span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Address of Principal Executive Offices, and Zip Code)</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d836691e227-wk-Fact-7D27CEB7D65A5FD390CD85FF13842CA5" name="dei:CityAreaCode" contextRef="D2020Q1F8K1720">609</ix:nonNumeric></span></span><span style="font-family:inherit;font-size:10pt;">-</span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d836691e231-wk-Fact-18F25DFDBDC95B0D888C733D5AF02246" name="dei:LocalPhoneNumber" contextRef="D2020Q1F8K1720">662-2000</ix:nonNumeric></span></span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Registrant&#8217;s Telephone Number, Including Area Code</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;text-indent:192px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(Former Name or Former Address, if Changed Since Last Report.)</span></div><div style="line-height:120%;text-align:left;padding-left:38px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:38px;text-indent:-2px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:65px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:34px;"><span style="font-family:Arial Unicode MS;font-size:10pt;"> </span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:65px;text-indent:696px;font-size:10pt;"><span><ix:nonNumeric id="d836691e263-wk-Fact-D50727BD9B705BF2BC7303C7A53ECE81" name="dei:SolicitingMaterial" contextRef="D2020Q1F8K1720" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="line-height:120%;text-align:left;padding-left:65px;text-indent:48px;font-size:10pt;"><span><ix:nonNumeric id="d836691e270-wk-Fact-8588292809E251338664E6E60A75CCC5" name="dei:PreCommencementTenderOffer" contextRef="D2020Q1F8K1720" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="line-height:120%;text-align:left;padding-left:65px;text-indent:48px;font-size:10pt;"><span><ix:nonNumeric id="d836691e277-wk-Fact-D8C298209E5C5BCCB9AAFE1B2314C9EF" name="dei:PreCommencementIssuerTenderOffer" contextRef="D2020Q1F8K1720" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:706px;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:233px;"></td><td style="width:204px;"></td><td style="width:269px;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Title of each class</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Trading Symbol(s)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Name of each exchange on which registered</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d836691e317-wk-Fact-F7A49925964458E99BE3B21750AE59E1" name="dei:Security12bTitle" contextRef="D2020Q1F8K1720">Common Stock Par Value $0.01</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d836691e322-wk-Fact-700BA1D88B265F6690B03493B4CC6E45" name="dei:TradingSymbol" contextRef="D2020Q1F8K1720">FOLD</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d836691e327-wk-Fact-33929DC6762F5B5A97379B874002DAE0" name="dei:SecurityExchangeName" contextRef="D2020Q1F8K1720" format="ixt-sec:exchnameen">NASDAQ</ix:nonNumeric></span></span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2).  Emerging growth company </span><span><ix:nonNumeric id="d836691e332-wk-Fact-D00703FF23B35F529EBD4164CF36CBF6" name="dei:EntityEmergingGrowthCompany" contextRef="D2020Q1F8K1720" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-family:Arial Unicode MS;font-size:10pt;">&#9744;</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial Unicode MS;font-size:10pt;"><br/></span></div><div><a id="s65F60554277B58A7B4F9D449769585B9"></a></div><div style="line-height:232%;text-align:left;padding-left:38px;text-indent:-2px;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:232%;text-align:left;padding-left:38px;text-indent:-2px;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:232%;text-align:left;padding-left:38px;text-indent:-2px;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:38px;text-indent:-2px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 8.01 Other Events</span></div><div style="line-height:120%;text-align:left;padding-left:38px;text-indent:-2px;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:36px;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On January 7, 2020, Amicus Therapeutics, Inc. announced clinical, regulatory and manufacturing advancements for AT-GAA, its investigational therapy for Pompe disease. A copy of this press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div><div style="line-height:120%;padding-left:36px;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:36px;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:232%;padding-bottom:12px;text-align:left;padding-left:38px;text-indent:-2px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 9.01 Financial Statements and Exhibits</span></div><div style="line-height:174%;text-align:left;padding-left:38px;text-indent:-2px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">(d) Exhibits:</span></div><div style="line-height:174%;text-align:left;padding-left:38px;text-indent:-2px;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:597px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:133px;"></td><td style="width:464px;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit No.</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Description</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="exhibit99117.htm"><span style="font-family:inherit;font-size:10pt;">99.1</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="exhibit99117.htm"><span style="font-family:inherit;font-size:10pt;">January 7, 2020 Press Release</span></a></div></td></tr></table></div></div><div><br/></div><div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><a id="s4192D50407FC5D28B307046A0805A1B7"></a></div><div style="line-height:232%;padding-bottom:0px;text-align:center;padding-left:37px;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Signature Page</span></div><div style="line-height:232%;padding-bottom:0px;text-align:left;padding-left:37px;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="line-height:174%;padding-bottom:0px;text-align:left;padding-left:37px;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:601px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:285px;"></td><td style="width:316px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">AMICUS THERAPEUTICS, INC.</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Date: January 7, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-decoration:underline;">By:  /s/ Ellen S. Rosenberg</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Name: Ellen S. Rosenberg</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Title: Chief Legal Officer and Corporate Secretary</span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div>	</div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit99117.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s712D5AB6AE98A1D90C3E7E065FB95258"></a></div><div><div style="line-height:130%;padding-bottom:10px;text-align:left;"><img src="exhibit991image1a19.jpg" alt="exhibit991image1a19.jpg" style="height:48px;width:142px;"></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:18pt;"><font style="font-family:Arial;font-size:18pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:18pt;"><font style="font-family:Arial;font-size:18pt;font-weight:bold;">Amicus Therapeutics Provides Updates on Clinical, Regulatory and Manufacturing Advancements for AT-GAA for Pompe Disease</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;font-style:italic;font-weight:bold;">123 Patients Enrolled in Phase 3 PROPEL Study &#8211; Enrollment Completed in 4Q2019</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;font-style:italic;font-weight:bold;">Company Plans to Apply for and Initiate a Rolling Biologics License Application (BLA) for AT-GAA in 2020 with Addition of Full Clinical Results in 1H2021 to Support Full Approval under Fast Track Designation</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;font-style:italic;font-weight:bold;">Promising Innovative Medicine (PIM) Designation Issued by British MHRA with Potential for Early Access for Pompe Patients in United Kingdom Based on Phase 2 Results</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;font-style:italic;font-weight:bold;">Biologics Manufacturing with WuXi Biologics on Track with PPQ Runs at Commercial Scale  </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">CRANBURY, NJ, Jan. 7, 2020</font><font style="font-family:Arial;font-size:10pt;">&#32;&#8211; Amicus Therapeutics (Nasdaq: FOLD), a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel medicines for rare metabolic diseases,</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:Arial;font-size:10pt;">today announced clinical, regulatory and manufacturing advancements for AT-GAA, its investigational therapy for Pompe disease. Pompe disease is an inherited lysosomal disorder caused by an enzyme deficiency that leads to accumulation of glycogen (disease substrate) in cells and is characterized by severe muscle weakness that worsens over time.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">John F. Crowley, Chairman and Chief Executive Officer of Amicus Therapeutics stated, &#8220;Our team&#8217;s efforts to bring AT-GAA to all patients living with Pompe around the world continues at a momentous pace and with great passion. We know that there is an urgent need for new, second-generation therapies for people living with lysosomal disorders, especially in Pompe disease. Regulatory agencies in the U.S. and now the U.K., have recognized the highly differentiated clinical data set and the great potential for AT-GAA to meet the currently unmet medical needs in Pompe disease through the granting of Breakthrough Therapy Designation and the Promising Innovative Medicine Designation, respectively. Amicus now plans to apply for and initiate a rolling submission of the AT-GAA BLA in the U.S. later this year. These designations, together with the results from the Phase 2 study and the now fully enrolled PROPEL pivotal study, support our strategy to advance AT-GAA as quickly as possible with the potential to become the new standard of care for all persons living with Pompe disease.&#8221;</font></div><div style="line-height:120%;"><hr></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">Achieved Full Enrollment of Phase 3 PROPEL Study</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">During the fourth quarter of 2019, Amicus completed and exceeded patient enrollment in the global Phase 3 PROPEL clinical study for Pompe disease. A total of 59 clinical sites have enrolled 123 patients globally.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">PROPEL is a 52-week, double-blind randomized study designed to assess the efficacy, safety and tolerability of AT-GAA compared to the current standard of care, alglucosidase alfa, an enzyme replacement therapy (ERT) in adults with late-onset Pompe disease (LOPD). The PROPEL study is intended to assess superiority of AT-GAA compared to alglucosidase alfa in both ERT switch and ERT na&#239;ve patients. The primary efficacy endpoint is change in six-minute walk distance from baseline to Week 52. Secondary endpoints include respiratory measures and additional measures of muscle function and muscle strength. More information, including a list of participating sites, is available at www.clinicaltrials.gov: NCT03729362.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">Rolling Biologics License Application (BLA) for AT-GAA</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:10pt;">Amicus plans to apply for and initiate a rolling submission of the BLA for AT-GAA in late-onset Pompe disease and to complete final submission in the first half of 2021. A rolling submission allows the Company to submit portions of the regulatory application to the U.S. Food and Drug Administration (FDA) as they are completed, rather than waiting until every section of the BLA is complete to submit the entire application for review</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:10pt;">The U.S. FDA previously granted Breakthrough Therapy Designation to AT-GAA for the treatment of late onset Pompe disease based on clinical efficacy results from the Phase 1/2 clinical study, including improvements in six-minute walk distance, an integrated measure of disease progression that evaluates the cardiopulmonary and musculoskeletal systems, as well as comparison to natural history of treated patients. </font><font style="font-family:inherit;font-size:12pt;">&#32;</font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:130%;padding-bottom:10px;text-align:left;"><img src="exhibit991image1a19.jpg" alt="exhibit991image1a19.jpg" style="height:48px;width:142px;"></div></div><div><br></div><div style="line-height:120%;"><hr></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">Promising Innovative Medicine (PIM) designation for AT-GAA </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The British Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Promising Innovative Medicine (PIM) designation for AT-GAA in late onset Pompe disease. A PIM designation signifies that a clinical program may be eligible for the Early Access to Medicines Scheme (EAMS), which works to provide patients with life threatening or seriously debilitating conditions access to medicines with the potential to address an unmet medical need. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">PIM designation for AT-GAA is based on clinical efficacy results from the Phase 1/2 clinical study, including improvements in six-minute walk distance, an integrated measure of disease progression that evaluates the cardiopulmonary and musculoskeletal systems, as well as comparison to natural history of treated patients. Amicus is evaluating the EAMS program and will provide a future update.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">Biologics Manufacturing with WuXi Biologics on Track  </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Process performance qualification (PPQ) runs have been initiated with the Company&#8217;s key strategic partner, WuXi Biologics. The PPQ runs will serve as the foundation for the Chemistry, Manufacturing, and Control (CMC) module for a BLA submission. The manufacturing focus remains on AT-GAA inventory build, which will support: the clinical studies underway, further studies including in pediatrics, as well as to supply the early commercial inventory. WuXi Biologics will enable and support Amicus with its dual sourcing strategy and manufacture at two sites across their network, including its new facility in Ireland, which remains on-track.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">About AT-GAA</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">AT-GAA is an investigational therapy that consists of cipaglucosidase alfa (ATB200), a unique recombinant human acid alpha-glucosidase (rhGAA) enzyme with optimized carbohydrate structures, particularly mannose-6 phosphate (M6P), to enhance uptake into cells, co-administered with miglustat (AT2221), a pharmacological chaperone. In preclinical studies, AT-GAA was associated with increased tissue enzyme levels, reduced glycogen levels in muscle, and improvements in muscle strength. A global Phase 1/2 study (ATB200-02) is ongoing to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics of AT-GAA. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Amicus is also conducting an ongoing global Phase 3 clinical study (ATB200-03, or PROPEL) of AT-GAA in adult patients with late onset Pompe disease</font><font style="font-family:Arial;font-size:10pt;color:#0000ff;">. </font><font style="font-family:Arial;font-size:10pt;">PROPEL is a 52-week, double-blind randomized study designed to assess the efficacy, safety and tolerability of AT-GAA compared to the current standard of care, alglucosidase alfa, an enzyme replacement therapy (ERT). The primary endpoint is six-minute walk distance, an integrated measure of disease progression that evaluates the cardiopulmonary and musculoskeletal systems essential to performing the activities of daily living for patients with Pompe disease. More information, including a list of participating sites, is available at www.clinicaltrials.gov: NCT03729362. In addition, Amicus is enrolling an open-label, uncontrolled, multicenter study to evaluate the PK, safety, efficacy, and PD of AT-GAA in pediatric patients aged 12 to &lt;18 years with LOPD More information, including a list of participating sites, is available at www.clinicaltrials.gov: NCT03911505</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">About Pompe Disease</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Pompe disease is an inherited lysosomal disorder caused by deficiency of the enzyme acid alpha-glucosidase (GAA). Reduced or absent levels of GAA levels lead to accumulation of glycogen in cells, which is believed to result in the clinical manifestations of Pompe disease. The disease can be debilitating and is characterized by severe muscle weakness that worsens over time. Pompe disease ranges from a rapidly fatal infantile form with significant impacts to heart function to a more slowly progressive, late onset form primarily affecting skeletal muscle. It is estimated that Pompe disease affects approximately 5,000 to 10,000 people worldwide. </font></div><div style="line-height:120%;"><hr></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">About&#160;Amicus Therapeutics</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for rare metabolic diseases. For more information please visit the company&#8217;s website at www.amicusrx.com, and follow us on&#160;Twitter&#160;and&#160;LinkedIn.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:130%;padding-bottom:10px;text-align:left;"><img src="exhibit991image1a19.jpg" alt="exhibit991image1a19.jpg" style="height:48px;width:142px;"></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">CONTACTS:</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Investors:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">Andrew Faughnan</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">Director, Investor Relations</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">afaughnan@amicusrx.com  </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">(609) 662-3809</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Media:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Christopher Byrne</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:Arial;font-size:10pt;">Executive Director, Corporate Communications</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:Arial;font-size:10pt;">cbyrne@amicusrx.com </font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:Arial;font-size:10pt;">(609) 662-2798</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">FOLD&#8211;G</font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>fold-20200107.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<xsd:schema attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.amicustherapeutics.com/20200107" xmlns:fold="http://www.amicustherapeutics.com/20200107" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import namespace="http://fasb.org/srt-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-roles/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/currency/2019-01-31" schemaLocation="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/exch/2019-01-31" schemaLocation="https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="fold-20200107_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="fold-20200107_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="fold-20200107_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="fold-20200107_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple" />
      <link:roleType id="CoverPage" roleURI="http://www.amicustherapeutics.com/role/CoverPage">
        <link:definition>0001000 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>4
<FILENAME>fold-20200107_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.amicustherapeutics.com/role/CoverPage" xlink:href="fold-20200107.xsd#CoverPage" xlink:type="simple" />
  <link:calculationLink xlink:role="http://www.amicustherapeutics.com/role/CoverPage" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>fold-20200107_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.amicustherapeutics.com/role/CoverPage" xlink:href="fold-20200107.xsd#CoverPage" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple" />
  <link:definitionLink xlink:role="http://www.amicustherapeutics.com/role/CoverPage" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>fold-20200107_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_CoverAbstract_4C427090B42E9AA8E4ECFB8B35FB5914_label_en-US" xlink:label="lab_dei_CoverAbstract_9F3C64A71BB85245BA32BDF57A8A76A6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover page.</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_9F3C64A71BB85245BA32BDF57A8A76A6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract_9F3C64A71BB85245BA32BDF57A8A76A6" xlink:to="lab_dei_CoverAbstract_9F3C64A71BB85245BA32BDF57A8A76A6" xlink:type="arc" />
    <link:label id="lab_dei_DocumentType_5BB88C907F9E1ED8D837FB8B35FB08CC_terseLabel_en-US" xlink:label="lab_dei_DocumentType_D1723F7A5BCD57EAB372B8A6FF7D3F94" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_5BB88C907F9E1ED8D837FB8B35FB08CC_label_en-US" xlink:label="lab_dei_DocumentType_D1723F7A5BCD57EAB372B8A6FF7D3F94" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_D1723F7A5BCD57EAB372B8A6FF7D3F94" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType_D1723F7A5BCD57EAB372B8A6FF7D3F94" xlink:to="lab_dei_DocumentType_D1723F7A5BCD57EAB372B8A6FF7D3F94" xlink:type="arc" />
    <link:label id="lab_dei_DocumentPeriodEndDate_E2DF90494885C208E6BFFB8B35FB7E2F_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_DE22725676B2595BBAC8D6129C78305F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_E2DF90494885C208E6BFFB8B35FB7E2F_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_DE22725676B2595BBAC8D6129C78305F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_DE22725676B2595BBAC8D6129C78305F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate_DE22725676B2595BBAC8D6129C78305F" xlink:to="lab_dei_DocumentPeriodEndDate_DE22725676B2595BBAC8D6129C78305F" xlink:type="arc" />
    <link:label id="lab_dei_EntityRegistrantName_C9A78BB3F84A66307AA2FB8B35FFD04F_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName_E76B4DFD479A5BA2AF7D84B2F8AA7B7F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_C9A78BB3F84A66307AA2FB8B35FFD04F_label_en-US" xlink:label="lab_dei_EntityRegistrantName_E76B4DFD479A5BA2AF7D84B2F8AA7B7F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_E76B4DFD479A5BA2AF7D84B2F8AA7B7F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName_E76B4DFD479A5BA2AF7D84B2F8AA7B7F" xlink:to="lab_dei_EntityRegistrantName_E76B4DFD479A5BA2AF7D84B2F8AA7B7F" xlink:type="arc" />
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_FC70AF031603AF7AC9C5FB8B35FF61F2_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode_47B753F1A7CB5254812ACA6F9F1D55EA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_FC70AF031603AF7AC9C5FB8B35FF61F2_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode_47B753F1A7CB5254812ACA6F9F1D55EA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_47B753F1A7CB5254812ACA6F9F1D55EA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode_47B753F1A7CB5254812ACA6F9F1D55EA" xlink:to="lab_dei_EntityIncorporationStateCountryCode_47B753F1A7CB5254812ACA6F9F1D55EA" xlink:type="arc" />
    <link:label id="lab_dei_EntityFileNumber_3493F1314C92C234EFE3FB8B360040E8_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber_337FFCB9A80F54519F1BA98A183CFC34" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_3493F1314C92C234EFE3FB8B360040E8_label_en-US" xlink:label="lab_dei_EntityFileNumber_337FFCB9A80F54519F1BA98A183CFC34" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_337FFCB9A80F54519F1BA98A183CFC34" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber_337FFCB9A80F54519F1BA98A183CFC34" xlink:to="lab_dei_EntityFileNumber_337FFCB9A80F54519F1BA98A183CFC34" xlink:type="arc" />
    <link:label id="lab_dei_EntityTaxIdentificationNumber_75F41C1B442F950F08ADFB8B36008604_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber_61E39C05BE475606B25007A24C758D8A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_75F41C1B442F950F08ADFB8B36008604_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber_61E39C05BE475606B25007A24C758D8A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_61E39C05BE475606B25007A24C758D8A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber_61E39C05BE475606B25007A24C758D8A" xlink:to="lab_dei_EntityTaxIdentificationNumber_61E39C05BE475606B25007A24C758D8A" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressAddressLine1_DE8FDBE29AD24C2FD909FB8B360097D8_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1_8FDBCAF6D66C55D19A1965A3EC6F20A5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_DE8FDBE29AD24C2FD909FB8B360097D8_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1_8FDBCAF6D66C55D19A1965A3EC6F20A5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_8FDBCAF6D66C55D19A1965A3EC6F20A5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1_8FDBCAF6D66C55D19A1965A3EC6F20A5" xlink:to="lab_dei_EntityAddressAddressLine1_8FDBCAF6D66C55D19A1965A3EC6F20A5" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressCityOrTown_12F5C937B3E05871D498FB8B36005910_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown_8FFA1F93293E5C46B198161AD1B661DE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_12F5C937B3E05871D498FB8B36005910_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown_8FFA1F93293E5C46B198161AD1B661DE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_8FFA1F93293E5C46B198161AD1B661DE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown_8FFA1F93293E5C46B198161AD1B661DE" xlink:to="lab_dei_EntityAddressCityOrTown_8FFA1F93293E5C46B198161AD1B661DE" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressStateOrProvince_7454978A457461526264FB8B36006AFC_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince_0197E5D723FF511FBF8CFA72D06FEDFE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_7454978A457461526264FB8B36006AFC_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince_0197E5D723FF511FBF8CFA72D06FEDFE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_0197E5D723FF511FBF8CFA72D06FEDFE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince_0197E5D723FF511FBF8CFA72D06FEDFE" xlink:to="lab_dei_EntityAddressStateOrProvince_0197E5D723FF511FBF8CFA72D06FEDFE" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressPostalZipCode_07B48D93EEC148E3937BFB8B3600A5BC_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode_AE62DE34CD06522392C8FC284968FE13" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_07B48D93EEC148E3937BFB8B3600A5BC_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode_AE62DE34CD06522392C8FC284968FE13" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_AE62DE34CD06522392C8FC284968FE13" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode_AE62DE34CD06522392C8FC284968FE13" xlink:to="lab_dei_EntityAddressPostalZipCode_AE62DE34CD06522392C8FC284968FE13" xlink:type="arc" />
    <link:label id="lab_dei_CityAreaCode_4030DB81F30F69D15866FB8B36004C15_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode_656D716551375CFC935FDE0280DA95EF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_4030DB81F30F69D15866FB8B36004C15_label_en-US" xlink:label="lab_dei_CityAreaCode_656D716551375CFC935FDE0280DA95EF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_656D716551375CFC935FDE0280DA95EF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode_656D716551375CFC935FDE0280DA95EF" xlink:to="lab_dei_CityAreaCode_656D716551375CFC935FDE0280DA95EF" xlink:type="arc" />
    <link:label id="lab_dei_LocalPhoneNumber_C45F05B64E4A3593A0AEFB8B36003A64_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber_3B50196B0F08528E92A71ABDF2FAD04B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_C45F05B64E4A3593A0AEFB8B36003A64_label_en-US" xlink:label="lab_dei_LocalPhoneNumber_3B50196B0F08528E92A71ABDF2FAD04B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_3B50196B0F08528E92A71ABDF2FAD04B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber_3B50196B0F08528E92A71ABDF2FAD04B" xlink:to="lab_dei_LocalPhoneNumber_3B50196B0F08528E92A71ABDF2FAD04B" xlink:type="arc" />
    <link:label id="lab_dei_WrittenCommunications_6E8387A29FE6966E9DBCFB8B3600122F_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications_45463E8752C558BCA3C920CF0F2C024E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_6E8387A29FE6966E9DBCFB8B3600122F_label_en-US" xlink:label="lab_dei_WrittenCommunications_45463E8752C558BCA3C920CF0F2C024E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_dei_WrittenCommunications_45463E8752C558BCA3C920CF0F2C024E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications_45463E8752C558BCA3C920CF0F2C024E" xlink:to="lab_dei_WrittenCommunications_45463E8752C558BCA3C920CF0F2C024E" xlink:type="arc" />
    <link:label id="lab_dei_SolicitingMaterial_AF4F815BADECFF8CE801FB8B3600C77B_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial_75ECAB8444D652A0A0101184D2CF8C64" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_AF4F815BADECFF8CE801FB8B3600C77B_label_en-US" xlink:label="lab_dei_SolicitingMaterial_75ECAB8444D652A0A0101184D2CF8C64" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_dei_SolicitingMaterial_75ECAB8444D652A0A0101184D2CF8C64" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial_75ECAB8444D652A0A0101184D2CF8C64" xlink:to="lab_dei_SolicitingMaterial_75ECAB8444D652A0A0101184D2CF8C64" xlink:type="arc" />
    <link:label id="lab_dei_PreCommencementTenderOffer_4BE7EB10C2A7487C24ABFB8B3603247A_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer_329DE73ECFCB55F7B9162AFE2D86630E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_4BE7EB10C2A7487C24ABFB8B3603247A_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer_329DE73ECFCB55F7B9162AFE2D86630E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_dei_PreCommencementTenderOffer_329DE73ECFCB55F7B9162AFE2D86630E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer_329DE73ECFCB55F7B9162AFE2D86630E" xlink:to="lab_dei_PreCommencementTenderOffer_329DE73ECFCB55F7B9162AFE2D86630E" xlink:type="arc" />
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_D217D792B97B2458D714FB8B36043C5A_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer_801ED63CF5A350A58533CB5308F00CD0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_D217D792B97B2458D714FB8B36043C5A_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer_801ED63CF5A350A58533CB5308F00CD0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_801ED63CF5A350A58533CB5308F00CD0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer_801ED63CF5A350A58533CB5308F00CD0" xlink:to="lab_dei_PreCommencementIssuerTenderOffer_801ED63CF5A350A58533CB5308F00CD0" xlink:type="arc" />
    <link:label id="lab_dei_Security12bTitle_C34F8FFD5BDF7D3F0A99FB8B360427E3_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle_F8306203410F50BEB2BDD15D65A80658" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of each class</link:label>
    <link:label id="lab_dei_Security12bTitle_C34F8FFD5BDF7D3F0A99FB8B360427E3_label_en-US" xlink:label="lab_dei_Security12bTitle_F8306203410F50BEB2BDD15D65A80658" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_F8306203410F50BEB2BDD15D65A80658" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle_F8306203410F50BEB2BDD15D65A80658" xlink:to="lab_dei_Security12bTitle_F8306203410F50BEB2BDD15D65A80658" xlink:type="arc" />
    <link:label id="lab_dei_TradingSymbol_B5FF41C1E5E8B42CC940FB8B3606FC16_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol_A30EF3D80AD45AC7836C4A914D2A27F9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_B5FF41C1E5E8B42CC940FB8B3606FC16_label_en-US" xlink:label="lab_dei_TradingSymbol_A30EF3D80AD45AC7836C4A914D2A27F9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_A30EF3D80AD45AC7836C4A914D2A27F9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol_A30EF3D80AD45AC7836C4A914D2A27F9" xlink:to="lab_dei_TradingSymbol_A30EF3D80AD45AC7836C4A914D2A27F9" xlink:type="arc" />
    <link:label id="lab_dei_SecurityExchangeName_3185F17F455395AA30E2FB8B3606F5E8_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName_8473CF18B23A53349506C28E332EDD8C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_3185F17F455395AA30E2FB8B3606F5E8_label_en-US" xlink:label="lab_dei_SecurityExchangeName_8473CF18B23A53349506C28E332EDD8C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_8473CF18B23A53349506C28E332EDD8C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName_8473CF18B23A53349506C28E332EDD8C" xlink:to="lab_dei_SecurityExchangeName_8473CF18B23A53349506C28E332EDD8C" xlink:type="arc" />
    <link:label id="lab_dei_EntityEmergingGrowthCompany_4608D1397FE638427D35FB8B3606CA13_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany_933CC8EFA5E559E294BAE82D48B8411F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_4608D1397FE638427D35FB8B3606CA13_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany_933CC8EFA5E559E294BAE82D48B8411F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_933CC8EFA5E559E294BAE82D48B8411F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany_933CC8EFA5E559E294BAE82D48B8411F" xlink:to="lab_dei_EntityEmergingGrowthCompany_933CC8EFA5E559E294BAE82D48B8411F" xlink:type="arc" />
    <link:label id="lab_dei_EntityCentralIndexKey_40DE1FEBA7B80A3FCF07FB8B36064353_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey_F5610CE85CC15242B7917F0CCC2E671F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_40DE1FEBA7B80A3FCF07FB8B36064353_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey_F5610CE85CC15242B7917F0CCC2E671F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_F5610CE85CC15242B7917F0CCC2E671F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey_F5610CE85CC15242B7917F0CCC2E671F" xlink:to="lab_dei_EntityCentralIndexKey_F5610CE85CC15242B7917F0CCC2E671F" xlink:type="arc" />
    <link:label id="lab_dei_AmendmentFlag_C4F3C7D3F406D5343024FB8B360626C2_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag_5039D0098296549D8E24EA911D9F477D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_C4F3C7D3F406D5343024FB8B360626C2_label_en-US" xlink:label="lab_dei_AmendmentFlag_5039D0098296549D8E24EA911D9F477D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_5039D0098296549D8E24EA911D9F477D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag_5039D0098296549D8E24EA911D9F477D" xlink:to="lab_dei_AmendmentFlag_5039D0098296549D8E24EA911D9F477D" xlink:type="arc" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>fold-20200107_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.amicustherapeutics.com/role/CoverPage" xlink:href="fold-20200107.xsd#CoverPage" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:presentationLink xlink:role="http://www.amicustherapeutics.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_9F3C64A71BB85245BA32BDF57A8A76A6" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_D1723F7A5BCD57EAB372B8A6FF7D3F94" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9F3C64A71BB85245BA32BDF57A8A76A6" xlink:to="loc_dei_DocumentType_D1723F7A5BCD57EAB372B8A6FF7D3F94" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_DE22725676B2595BBAC8D6129C78305F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9F3C64A71BB85245BA32BDF57A8A76A6" xlink:to="loc_dei_DocumentPeriodEndDate_DE22725676B2595BBAC8D6129C78305F" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_E76B4DFD479A5BA2AF7D84B2F8AA7B7F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9F3C64A71BB85245BA32BDF57A8A76A6" xlink:to="loc_dei_EntityRegistrantName_E76B4DFD479A5BA2AF7D84B2F8AA7B7F" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_47B753F1A7CB5254812ACA6F9F1D55EA" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9F3C64A71BB85245BA32BDF57A8A76A6" xlink:to="loc_dei_EntityIncorporationStateCountryCode_47B753F1A7CB5254812ACA6F9F1D55EA" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_337FFCB9A80F54519F1BA98A183CFC34" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9F3C64A71BB85245BA32BDF57A8A76A6" xlink:to="loc_dei_EntityFileNumber_337FFCB9A80F54519F1BA98A183CFC34" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_61E39C05BE475606B25007A24C758D8A" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9F3C64A71BB85245BA32BDF57A8A76A6" xlink:to="loc_dei_EntityTaxIdentificationNumber_61E39C05BE475606B25007A24C758D8A" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_8FDBCAF6D66C55D19A1965A3EC6F20A5" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9F3C64A71BB85245BA32BDF57A8A76A6" xlink:to="loc_dei_EntityAddressAddressLine1_8FDBCAF6D66C55D19A1965A3EC6F20A5" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_8FFA1F93293E5C46B198161AD1B661DE" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9F3C64A71BB85245BA32BDF57A8A76A6" xlink:to="loc_dei_EntityAddressCityOrTown_8FFA1F93293E5C46B198161AD1B661DE" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_0197E5D723FF511FBF8CFA72D06FEDFE" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9F3C64A71BB85245BA32BDF57A8A76A6" xlink:to="loc_dei_EntityAddressStateOrProvince_0197E5D723FF511FBF8CFA72D06FEDFE" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_AE62DE34CD06522392C8FC284968FE13" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9F3C64A71BB85245BA32BDF57A8A76A6" xlink:to="loc_dei_EntityAddressPostalZipCode_AE62DE34CD06522392C8FC284968FE13" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_656D716551375CFC935FDE0280DA95EF" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9F3C64A71BB85245BA32BDF57A8A76A6" xlink:to="loc_dei_CityAreaCode_656D716551375CFC935FDE0280DA95EF" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_3B50196B0F08528E92A71ABDF2FAD04B" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9F3C64A71BB85245BA32BDF57A8A76A6" xlink:to="loc_dei_LocalPhoneNumber_3B50196B0F08528E92A71ABDF2FAD04B" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_dei_WrittenCommunications_45463E8752C558BCA3C920CF0F2C024E" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9F3C64A71BB85245BA32BDF57A8A76A6" xlink:to="loc_dei_WrittenCommunications_45463E8752C558BCA3C920CF0F2C024E" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_dei_SolicitingMaterial_75ECAB8444D652A0A0101184D2CF8C64" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9F3C64A71BB85245BA32BDF57A8A76A6" xlink:to="loc_dei_SolicitingMaterial_75ECAB8444D652A0A0101184D2CF8C64" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_dei_PreCommencementTenderOffer_329DE73ECFCB55F7B9162AFE2D86630E" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9F3C64A71BB85245BA32BDF57A8A76A6" xlink:to="loc_dei_PreCommencementTenderOffer_329DE73ECFCB55F7B9162AFE2D86630E" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_801ED63CF5A350A58533CB5308F00CD0" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9F3C64A71BB85245BA32BDF57A8A76A6" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_801ED63CF5A350A58533CB5308F00CD0" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_F8306203410F50BEB2BDD15D65A80658" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9F3C64A71BB85245BA32BDF57A8A76A6" xlink:to="loc_dei_Security12bTitle_F8306203410F50BEB2BDD15D65A80658" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_A30EF3D80AD45AC7836C4A914D2A27F9" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9F3C64A71BB85245BA32BDF57A8A76A6" xlink:to="loc_dei_TradingSymbol_A30EF3D80AD45AC7836C4A914D2A27F9" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_8473CF18B23A53349506C28E332EDD8C" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9F3C64A71BB85245BA32BDF57A8A76A6" xlink:to="loc_dei_SecurityExchangeName_8473CF18B23A53349506C28E332EDD8C" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_933CC8EFA5E559E294BAE82D48B8411F" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9F3C64A71BB85245BA32BDF57A8A76A6" xlink:to="loc_dei_EntityEmergingGrowthCompany_933CC8EFA5E559E294BAE82D48B8411F" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_F5610CE85CC15242B7917F0CCC2E671F" xlink:type="locator" />
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9F3C64A71BB85245BA32BDF57A8A76A6" xlink:to="loc_dei_EntityCentralIndexKey_F5610CE85CC15242B7917F0CCC2E671F" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_5039D0098296549D8E24EA911D9F477D" xlink:type="locator" />
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9F3C64A71BB85245BA32BDF57A8A76A6" xlink:to="loc_dei_AmendmentFlag_5039D0098296549D8E24EA911D9F477D" xlink:type="arc" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>exhibit991image1a19.jpg
<TEXT>
begin 644 exhibit991image1a19.jpg
M_]C_X  02D9)1@ ! 0$ 1P!'  #_VP!#  (" @(" @(" @(" @(" P0# @(#
M! 4$! 0$! 4&!04%!04%!@8'!P@'!P8)"0H*"0D,# P,# P,# P,# P,# S_
MVP!# 0,# P4$!0D&!@D-"PD+#0\.#@X.#P\,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" )@!Q,# 1$  A$! Q$!_\0
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M4V*"HL+2!Q5#<Q<D8^+Q)43_V@ , P$  A$#$0 _ +_
M
M
M
M
M                                                       !K7+-
M9-*,$D?3Y?J-AF/UD>_-;JNX0-JNG?\ L?G65?YIGX;*\5B>.U;JJCS1.G;N
M8.)S/"X?BN7*8GIX^S>TY4\;W"Y22K#+JG3N>G>L-IN\S?Y\5$YOY3:4[)9I
M/_%_53_DU=6U>61_R^JK_%_=%QM<+UPG;3P:J4C)'=SJFV7:F9WHGUR>C8SQ
M]9\KV3S.F-9M>NF>ZI]IVKRRJ=/"^JJ.^EO#$M3].<];OA>=8GE#]E5U/;:^
M"HF9MW\\3'J]OTH:C$Y?B,-\[;JIZ8T;;#8_#XGYJY35T3JSHQ&6
M
M
M
M
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MQ$*TSC9O%9;XU4<*C[4;NOF[O.LC*-H\+F/BTSP:_LS[N?O\R4)'V_
M
M
M
M
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MRQ*O1K+G\MO]^[T_=-TW>E=;0;&Q.M[!QQ\M'^/P[.9860;83&EG%SQ<E?\
ME\>WG6Z4M535M-3UM%405='5QLFI*N%Z21RQR)S,>Q[=T<UR+NBH5I53-,Z3
MO6335%4:QN?N?'T
M
M
M
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MT,B<S)(WMW145%Z*5!<MU6ZIIJC286W;N4W*8JIG6)?><',
M
M
M
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MIIJC286[;N4W*8JIG6)?><',
M
M
M
M                          &$:B:B8EI7B5TS7-;I':[):V>D[OEGE7ZW
M!!'WR22+T:U/G79$54R\#@;N,NQ:M1K5/YUGS,3&XVU@[4W;LZ4Q^=(\[GIX
MBN(K+>(++5NMU62UXK:WO9B>)L?O%21+^Z2>$DTB?#?]";-1$+LR/([65VN#
M3QUSY57/^'-"E\[SN[F=WA5<5,>33S?BCP;MI0               !/?@VXM
M:C1ZYT^GV=5<E1IA>:GWBMD5SW6.HE7K,Q.O['>[K(Q.Y??&]>9'PW:C9N,=
M3X:S'ZV/ZX^/-/5T3#9C:.<#5X&]\U/]$_#GCKZ;UJ6JIJVFIZVBJ(*NCJXV
M34E7"])(Y8Y$YF/8]NZ.:Y%W14*@JIFF=)WK<IJBJ-8W/W/CZ
M
M
M
M                                                 ,;R_+L>P/&K
MQE^5W*&T8_8J=:FY5\FZHUJ=$1K4W5SG*J-:U.JJJ(G4[\-AKF)N1;MQK5.Y
MT8G$V\-;FY<G2F-[GAXE>(W(^(/,/="I26U8;9'R18AC7-TBB<O6HGVZ.GE1
M$YE[D39J=$W6[LAR.WE=G2..N?*GW1YH4KGN=W,SNZSQ41Y,>^?/*-IO6C
M                !9YP.<6CL7JK?HSJ5=-\9KI$APC(JI_]CIG[(VBF>]>E
M.]?K:_$<NWP%]"O]KMF_#1.*L1XT>5'VO/'GY^?IWS[9/:/P,QA;\^+]6>;S
M3YN;FZ-US!5JSP
M
M
M
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M+:#Y33\FO3X\>3/VHYNF/7'6LE((G(
M
M
M
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MK+,1P?J3QTSYN;IC\5V[/YS3F6'X7UXXJH]_1/X)+FA;T
M
M
M
M                                        %>W'%Q0KI=89-,<'N'9Z
M@Y/3?]*W&!WIVBW2HJ<R*GP9YDZ,\6MW?T7D4FNR.S_RROY1=C]73N_BGX1R
M]G.AFUF?_(Z/ 6I_65;_ .&/C/)V\RC5555557=5[U+=5*_P
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MNG@Y.YR+U1=T7J4/B,/7A[E5NN-*J9TE>>'OT7[<7*)UIF-8>^=+N
M
M
M
M                                              $?^)#7BRZ Z>5>
M35?85N27+FHL-L+UZU=:K=^9Z(J+V,*>G(O3ILW?F<TW619/7F>(BW'DQQU3
MS1\9Y/P:;/,WHRW#S<GRIXJ8YY^$<OXN<?)<DO>87^[Y1DEQJ+M?K[525ETN
M,WPI99%W5=DV1$3N1$39$V1$1$+SL6*+%N+=$:4QQ0I"_?KOUS<KG6J>.7AG
M:Z@               !E>&X/E^H5\I\;PG'KIDMZJ>L=#11J]4;XOD=\&-B>
M+G*B)XJ8^*Q=K"T<.[5%-/G9&%PEW$U\"U3-4^99YHYY-E7MIKQK;D3XE7ED
M^HRP2)NGCRU5<YJI[%;"WYI2O\TV[^KA*?YJO=3\>Q/LLV&^MBJOY:??5\.U
M9-I_I%IGI;1I18#A=BQM.3DFK*>%'5<R)_=JN3FFD_EO4@>-S/$XR=;U<U=W
M5&Z$YP>6X;!QI9HBGOZYWR^76W&_JOT>U.QI&*^:[8S<X:1J-YE\X\V>Z!>7
MQVD1JG+*;_@,7:KYJH[->/U..:V/#X2[1STSVZ<7K<OAZ"4$   %H?D\.(!;
M)>9M#,GK-K3D,LE9@D\J]*>OVYJBCW7N;4(G.Q/[HBIU=(5]MODOA*/E=N..
MGBJ\\<D]7+YNA/\ 8K.?!U_)+D\4\=/FGECK[^E<B5<LX
M
M
M
M                                     \')\FLF&X]>,JR2OBMEBL-+
M)67.ND[F11INO3O55[D1.JKLB=3NP]BN_<BW1&M4\4.G$7Z+%N;E<Z4QQRYO
M.(36^^:]:BW++[EV]'9H-Z3$K"YV[:&@8OH-7;IVDGPY'>+EV3T4:B7KDF4T
M9;AXM4[]]4\\_#F4=G6;5YEB)N3NW4QS1\>=HPV[4@               ">_
M#GP+9IJJV@RO4%:W!,!GVEIXG,Y;K<HU[E@BD3WF-WA)(G5-E:QR+S$-SS:^
MS@M;=GQ[G]-/3SSYHZY3#)-DKV,TN7O$M_U5='-'GGJA<[IUI;@6D]BBQW <
M;H+!;VHGG#XF\U14O3]TJ9W;R2N]KE7U)LA5F.S"_C:^'>JUGU1T1R+1P67V
M,%1P+-.D>N>F>5L PF8 ?RYK7M5KD1S7)LYJ]45% Y5<XL/U+9IE^,*QT:XY
M>[A:UC=ONWS2H?#LO-U^)XGHK"7O#6:+GVJ8GMC5YZQ=GP-ZNW]FJ8[)T8N9
M#'  'V6ZX5MIN%#=;9534-QME1%5V^MA7EDAGA<CXY&+X*UR(J'&NB*Z9IJX
MXERHKFBJ*J=\.E+AQUDH]<M*;!FC%@CO;&^YV74$?_5[G3HG;=/!LB*V5B>#
M7HG?N4/GF5SEV*JM?5WT^>F=W9NGH7IDF9QF&%IN_6W5>:J/COZV]C3MN
M
M
M
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M2XKP57DW.+^;ZOPZU\Y3JWP
M
M              'DUE^L5OF;3U]ZM-#.Y[8VP5%1%&]7N3F:U&N<B[JG5$.R
MFS75QQ3,NNJ]13Q3,0]""H@JHFSTT\-1 _?DFB<CVKLNR[*G3O.$Q,<4N<3$
M[G['Q]
M
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M_(,779Y->+T9XX^'2OC)<P^782B[RZ<?I1O^+=1JFT
M
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MM5317&DQOA9=J[3=IBJB=8GE>F<',
M
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MOC1TQQ3ZM.Q<*5BLP
M
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MZ)[^E=.54M(
M
M "FORAW$ M]O<6AV,5N]HQV5E7G4\3O1J+ALCH:3=J[*VG1>9Z?W143HL9:6
MQ&2^#H^5W(XZO)\T<L]?=TJPVUSGPE?R2W/%3Y7GGDCJ[^A5^6 @(
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M/%V[O)$\?1/%/J=/"*BHBHNZ+W*>?U]O]
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M\)5IPHG2=/5ZDE30MZ
M              J-\IYF-0M5I?I_#(YM(V*LR"XP^#Y'*E+2N_D(DW\XLO\
MT_PL:7;W+Q4^^?<K?;W$SK:L]-7NCWJG2QU=     ].S7>OQ^\6J_6J=::Z6
M2L@K[;4IWQSTTB2Q/^AS44X7;=-VB:*MTQI/1+G:N56ZXKIWQ.O8ZI\;O4.2
M8[8<BIFJRGOUNI;C3L]3*J)LK4_$X\ZW[4VKE5$\DS'8]"V+L7;=-<<L1/:]
MHZG:
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M)9(:"%CE7JO7=/6>>\TKBO%W:HY:ZO:E?^6431A+5,\E%/LPV08+.
M
M                                        '\N<UC5<Y4:UJ;N<O1$1
M .=KB_UWDUPU4K9;75NEP;#UEM>'1-7>.5B._9%:GMJ7M14^T1B+U0N_9C)_
M]NPL<*/UE7'5[HZN_52FTN;_ .X8J>#/ZNGBI]\]?=HBD2-'0
M /IHZ.KN-926^WTM16U]=,RGHJ*!BR2RRRN1K(V,;NKG.<NR(A\JJBF-9W0Y
M4TS5.D;Y7^<'_"_1:%XLF09)3T]5JAD\#5O-3\)+;3.V<V@A=W=%3>5R?"=T
MZM:U5IC:?:"<QN\"CYJG=_%/VI]WXKCV:R",NM<.OYVK?YH^S'O3/(JE
M       5R^4RI6OT6PNMYEYJ?-::%&>"I-;J]RK]'9DYV!J_]VN/_C_NI0C;
MNG_TZ)_C_MJ4BELJI      NC\F;F2W+3O/<&FDYY<5O<-SI4=X4]UAY>1OL
M22D>[YW?,55M]A>!B+=[[5.G73/PGU+2V#Q7"P]RU]FK7JJCXQZUF) D[
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MWVS=]E]IYZQ6'JP]VJU5OIG3L>@,-B*<1:IN4[JHU[62G0[P
M                                          *[?*-:7566:6V34"UT
M_;UVF];(MS8UOI>YEQY(YG].J]E+'$OL:KW=-E)OL-F$6,559JW7(XO2C=VQ
MKZD*VWR^;V&IO4[[<\?HS\)T]:CTMM4X    -MZ%Z95NKVJV&X)2Q/=372N9
M)?)V_N%N@7M:R55]D351OK<J)XFMSC'Q@<+7>GDCB]*=WK;+*,!..Q5%F.6>
M/HC?ZG3M'''%&R*)C(XHVHV.-J;-:U.B(B)W;'G^9U7W$:/[
M
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M51V3Q=^B9;$8CP>-FC[5,]L<?=JO4*A6V
M               AKQTZH?J=:#WNVT50D-^U#D^IVW-1?32GG:KJZ3;OV[!'
M1[^"O:2G9#+_ )5CJ:I\FCQIZ?J^OCZD8VMS#Y+@:HCRJ_%ZOK>KBZW/J72I
MD    %WODX=3ER72Z]Z<U]0LEQT\KNTMS7+U]S+DKY6(GKY)VR[^I%:G3H5+
MMUE_@L53?C=7''Z5/X:+7V'Q_A<-58G?1/\ 35^.JQ<@Z;
M                                         ?#<K;07FW5]HNM)!<+9
M=*>2DN-#.U'Q303-5DD;VKWHYJ[*<[==5NJ*J9TF'&NBFNF::HUB7/OQ4\*V
M1:$9%5WBSTE9==++K4;V*^IO(M$LB]**M7XKV]S'KTD3;KS<S4NG9W:*WF5N
M*:ITNQOCG\\?GB4SM#L]<RZYPJ>.U.Z>;S3^>-$$DR-  #U;)9+QDMVM]AQ^
MV5MYO5UF;3VZV4D;I9II'=S6,;NJG7=NT6J)KKG2F-\R[+5JN[5%%$:S/(OQ
MX/>&"+0;&)[YDT=-4:F95"Q+U+&J2,MU+NCVT$3TZ*N_I2N3HYR(B;HQ%6F]
MI]H/]RN\"W\U3N\\_:^'XKAV9R#_ &VWPZ_G:M_FC[/Q_!,XBJ4
M
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MGZ9Y.U+]E<A^77/#78_5T_U3S=$<O8OA:UK&HUJ(UK4V:U.B(B%.K>?T
M        $%_*'PQR\.=6][>9U/D-KDA7Y+E61F_\URH2[8B=,QCT91+;6/\
M^?\ S0H3+D4^     !O;ACR7ZDN(#22]+(L4?U1TE!42I\6&Y+YC*J^SDG7?
MV&HS^QX? 7J?X9G[OC>YM\AO^!Q]FK^*(^]Q>]TO%"+V
M                          4+^4#U17.=:WXE15':6/3*F]RXVM7=KKC/
MRRUS_G1>2)?;&7'L7E_R?!>$GRKG'U?5]\]:H-LLP^48SP<>3;XNOE^'4@F2
M]$0    2IX,]3OU,->\2JJJH["QY8Y<:OWR>SKW-2!Z^I&5+8G*OR44CNU.7
M_+,!7$>53XT=6_U:I#LOC_DF.HF?)J\6>O=Z]'164>NP
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MU?D[D)S//,5F,_K:N+[,<5/9\=933+,DPN7Q^JIX_M3QU=OPT;R-0VP
M
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MZ?[B9B/;^13SE<HFBJ:9Y'HBW7%=,51ROO.#F
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MVFI;4
M
M                                                      PK4;.[
M)IE@^39YD4J1VK&J*2KF9OLZ9Z>C# S?X\TBMC;[50RL#@Z\9?ILT;ZI_,]6
M]BXW%T82S5>KW4Q^8Z]SF-SS-+WJ+F61YQD<_;WG)JZ2MK%3?E9SKZ$3-^YD
M;$1C4\&HB%_X/"T86S3:HW4QI^>G>H7&8JO%7JKM>^J=?ST,2,EC
M    ^FDI*JX5=+04--/65M;*R"CI(6J^2661R-8QC6]5<Y5V1$/E544QK.Z'
M*FF:ITC>Z)>$[A[H]!-.H::X0P29[D[8JW-+@W9W)(B+V5$QR?$IT<J=/A.5
MSNY4VH_:3.IS+$:Q\W3Q4_'K[M%U[.Y+&6X?2?G*N.KX=7>E,1Y(
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M#3R^-'3NGU:=BX K%98
M
M
M       !3CY1O6];M?+7HC8:M?,,=='=,U5BIM+72,WI*953^XQOYW)W<SV^
M+"T-ALIX%$XNN..KBIZ.6>N>+J\ZLMM\VX=<82C=3QU=/)'5''U^95R6$K\
M           "U'R>O#JVZ5?ZN^74#9+?;99*?3RCF3=LM5&JLGN&R^$*HL<?
MV_,[HK&J5WMMGG CY';GCGR^CDIZ]\^;I6%L7DG#GY7<CBCR.GEJZMT>?H7!
ME8K+               (.>4,^QQN7W^M7YQQ+=B?I&/1E$]M/H^?2A0<7*IX
M      !T,<"EU]T^&+3YCGH^:U2W6AF7T>G)<JE[$5&]VT;V]_7Q\2D]K[?
MS.YY])_IA=&R-SAY;;\VL?U2EX1E)0
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M%<15&Z7UG%R
M
M                                                          U9
MK3JC:]&]-<HU NB,F]QJ;:V4#EV\ZKIE[.F@3Q]*14YMNYN[O V&59?5C\33
M9IY=_FCEEK\TS"G X>J]5R;O//)#F5O]]NN3WN[9'?:V6XWF^5<U==*Z5=W2
MSSO5[W+\ZJ7]9LTV:(HHC2(C2%#7KM5ZN:ZYUF9UEY!V.L           &[N
M'S1F[:ZZF67"J'MJ>U[^>Y5=F)_6=MA<WMI$545.=VZ,CW^.Y-^FYJ<ZS6G+
ML-5=G?NICGJY/C/F;7)LKJS'$Q:C=OJGFIY?A'G=)U@L-HQ:R6G&[!0PVRR6
M.DBHK701? B@A:C&-3?JO1.]>J]ZE#WKU=ZN:ZYUJF=97I9LTV:(HHC2F.*'
ML'6[               ""7E%*I(.':2+DYO/<EMD*+O\'9)I=_\ X>Q,-AZ=
M<PZ*9]R([;5:9?\ S1[U#!<2H       %ZGDW;CYYH%=:17*JVC,+A3-:JIT
M:^EHY^B>K>5?RE0[=T<''Q//1'?5'N6WL/7PL#,<U<]U,K "%ID
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M ";'37'DW/&Z_K>OCZUQ['X_Y3@HHGRK?B]7U?5Q=2;1$TJ
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M^<MU4],3#;6,PP]_YNY35T3$L\,-E@
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MGNM5=!5\J?;I"]RM^932XC!W\/.EVBJGIB8;G#XRSB..U735T3$LN,9D@
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MI_\ 8M3_  ]T_BM#8*K_ ->[3_%WQ^"S@@">@
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M\T+?\(1+;/+_ )3@O"1Y5OCZOK?'J2S8['_)L;P)\FYQ=?U?AUK\BFEP@
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M^&J?97M=A,9XM?ZNOS[NJKXZ)M(J*B*B[HO<I$TK?Z
M              -&<1NL%)HAI/D>:N6)]Y5GN?B=&_;WZZ5*.2#HO>V/997I
M\EBFWR/+)S'%4VN3?5Z,;_ATRU.=YG&7X6J[R[J?2G=\>IS3UM95W&LJ[A7U
M$U975TSZBMJYG*^2665RN>][EZJKE7=5+ZIIBF-(W0HJJJ:IUG?+YCZX@
M        L(X =!/U0L\?JAD5'VF(Z=U#'6R.1N\=9>MD?"WKWI3(J2K]MV?>
MFY"ML\Y^2V/D]$^/<W^:G\=W:FFQV3_*;_RBN/$HW>>K\-_8O,*B6RQ:ZYOA
MUDW;=<GL5#(G[A)4Q]IT_O:+S?D,JU@;]WR:)GJ8MW'6+7EUQ'6P2NU\TNHE
M5K<@DK7IWMIJ6H=_XG,:W\IGT9!C*OJZ=,PU]>T&#I^OKT1+'I^)?3R+?LZ7
M)JK9=D[.FB3?V^G.PR*=F<5/+3V_@QZMI\+')5V?B^7^J?P'_NC+_P#,4O\
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M$IY\?G23?O[9MQ;MM[.S*T_U"IX[$^E_:LG8"KBOQZ/]RU\KA8@
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MFG-%RKS3Y-),C_!$AHY6JGT]H3W8"G_V;D_P^^$$V]J_]:W'\7N4N%JJM
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ME=G(P5'A[T?K9_HCXSR]G/KSVIVBG&U^!M3^JC^J?AS=O-I 0F:'
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MBE??Z@1^ILS_ !3W)_L#/ZZ['FCO7(E7+.
M          /CKZ^CM=!6W.X5$=);[=!)55U5)T;%#"U7R/=[&M3<Y44375%,
M;Y<:ZXHB:IW0YA-9=1:O5C4_--0*OG8F17&26WT[^^&BBVAI(E]K(&,:OMZG
MH'*\#&"PU%F/JQZ]\^M0>:8V<;B:[T_6GU<GJ:R,]@ '07P,:5_J;Z%66XUM
M.L5_U#?]45T5R>DV"9J-H8OF2!&OV7N<]Q2NU^8_*\=53'DT>+'3];U\74N;
M9++_ )+@8F?*K\:?=ZN/K3)(NDX!5-Y3#3+SBVX1JY04^\MOD7&\BD:G7L9>
M>HHGN]C7]JW?UO:A8VP6/TJKPT\OC1W3[NQ7FW> UIHQ,<GBSWQ[^U4(68K4
M    &ZN'C4UVD.L6$9Q)(]EKHJY*7(FIOZ5NK$["J]%/A<C'J]J?*:AJL[R_
MY=@Z[7+IQ>E'''P;7)<?\AQ=%WDUX^B>*?BZ9XY(Y8V2Q/9)%(U'1R-7=KFK
MU145._<H*8T7Q$ZO[         :AX@*9M7H3K- Z)9U7"+^Z.)-U59&6^=[-
MMOMD0V>2U<''6/\ LI]J&MSFG7 WO^NKV9<Q)?ZA     9=BF<9%A465,QVK
M\PDS"QRX]=JIJ+VJ4-1403S-B<BIRK)YNC'+\ASD\=S&Q&$MXC@<.->#5PHZ
M8B8COUZ=&3A\7<P_"X$Z<*G@ST3,3/=IT,1,EC-B::Z49_J[?DQW3_'*R_5[
M4:^ME9LRGI8W+MVE3.]49&W[I>O<FZ]#"Q^8V,#1P[U6D>N>B.5FX'+K^-KX
M%FG6?5'3/(L;PGR8M9+3P5.HFID-'4NV6>T8_2=LC?9YY4JSK_B""XO;^(G2
MQ:ZZI]T?%-\+L%,QK>N]5,>^?@V7)Y,G2Q8WI#J#J R54][>]*%[47VM2G;O
M^,P(V_Q7[NCU_%GSL'A?WE?J^",.K?D[=3<(H*N^8#>:/4NV4;5DGM<4"T5V
M1B)NJQTZOECFY?4V3G7XK%[B09;MOAL15%%Z/!SS[Z>WBT[-/.T&9;%8G#T\
M*S/A(YMU79R]NOF5[S0RT\LL$\4D$\#UCFAD16O8]J[.:YJ]45%)M$Z\<(9,
M:<4OS#X    "4.(<4>:X9H#DVB-HEJ(/=JXJZWW]K]GT5KJV.]T*2+Q:LLFR
MHO@CY?%6JD?Q.SUG$8^G%U<D;N>J/)GJCNAO\-M!>L8"K"T\L[^:F?*CKGOE
M%XD#0,[T\TSSG57((<8P+':_(;K)LZ9L*;0T\>^W:U$SMHXF?;/5$\._H8>-
MQ]C!6_"7JN#'?T1RLO!8"]C+G@[-/"GNZ9Y%D.#>3'KYZ6GJM1]28:"I>B+/
M9K!2]OR;^'GE2K$W^:';VJ07%[?Q$Z6+6OGJGW1\4YPFP4S&M^[IYJ8]\_!L
MZ3R9.E:L>D6H&H#)5:O9O=YBYJ.\%5$IV[_C0U\;?XK]W1Z_BSYV#PO[ROU?
M!H34;R:N?62FGK]-\PM.;MB17^XE?%[EUB_:Q2+)+ ]?NG1H;G [>6+DZ7Z)
MH\\>-'NGO:?&["W[<:V*XK\T^+/OCN5TY!CU]Q2\5^/9+:+A8KY:Y.RN%JK8
MG0S1.[_28Y$7JB[HOBG5.A.+-^B]1%=N8FF>6$)O6:[-<T5QI5')+QCM=0
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M$<<^ITWP0PTT,--3Q,AIZ=C8X(6)LUC&ILUJ(G<B(4#,ZSK*^8C2-(?J?'T
MU=K5IW3ZK:5YO@,[8^UR"V2,MLC^Z.NBVFHY%^YG8Q5]AL,JQLX+%47OLSQ]
M&Z?4P,TP48S"UV>>.+IWQZW,'54U115-11U<,E/54DCX:FGD39[)&+RN:Y/!
M45-CT#35%4:PH*JF:9TE^!]?     =#_  4ZI?JG:#XUYY/VU^PG_P!&KWNO
MI.\S:WS61?%>>G='NOBY'%([5Y?\CQU6GDU^-'7O]>JZME<P^5X&G7RJ/%GJ
MW>K1+4C:1@       & ZJP256E^I%+"G--4XM>(HF]V[GT4J)U,S+ITQ-J?X
MZ>^&'F,:X:Y'\%7=+EI/0SS\     !M+1K2C(=:M0K'@..[0SW)ZRW*YO;S1
MT5%%UGJ9$Z;\B=R;IS.5K=]U-?FF96\OP]5ZODW1SSR1^>1L,KRZYC\139HY
M=\\T<LNCS2S2O#M'L0M^&X5;(J&@I&M=6U:HGG%=4\J-DJJF3X\C]OF1-FM1
M&HB)1>8YC>Q]Z;MV=9]41S1YEX9?E]G VHM6HTCUS///G;&,%F@ "ICRA?#M
M;X*%-=\0MS*2=*B.EU%HZ=FS)>W=R07)43N=VBI%*OQN9CN_F5;(V)SRJ9^1
MW9]#WT^^.OS*YVTR2F(^5VX]/W5>Z>I4D64K@     #--/,#R#4[-,>P7&*?
MSB\Y%5MIJ?F^!$SX4L\B^#(F(KW>Q#%QN,MX.S5>N;J8_,=;*P6#N8N]3:M[
MZOSKU.D71?1G#]#\+H,0Q2CB21K&/OU\<Q$JKE5HGISSN[^]5Y6[[,3HA1.:
MYI>S&]-RY/1')3'-'YXUXY7E=K+[,6[<=,\M4\\_GB;;-:V0  BIQ2\,]@U^
MQ*:>EIZ>@U(L-,]<3OR;,[7;=WF-4[XT,B]V_P!;<O,G3F1TBV>S^YEEW2>.
MU/E1_='G[^Q'MH,BHS*UQ<5R/)GW3YN[M<\=QMU=:+A7VFZ4D]!<[742TEQH
M9F\LD,\+U9)&]J]SFN145"[J*Z:Z8JIXXE2M=$T5335Q3#XCDX@    NB\F7
MESKAIYJ#A4LO._&+Y!<J9J_%AND')RM]B/I'+\[BJ]OL-P<1;N_:IT^[/XK1
MV#Q/"P]RU]FK7[T?@LR("G@   1UXM(TDX<-76N8DB)8GNY53?JV6-R+]&VY
MN]FY_P#Z-GTFDVCC_P#G7O1<VI>ZC0    3@\GK&C^(^U.5B.6*Q75S7;;\J
M]DC=_9W[$2VVG_\ G3Z4)9L7'_\ 1CT97Z%-+A    !X&59/9<+QN]Y9D58R
M@L>/4<M=<ZMWQ8H6\R[)XN7N1/%=D0[L/AZ\1<IMT1K55.D.G$7Z+%NJY7.E
M-,:RYI-;M7+]K;J+?,\OBOB;6O["R6KFYF4-OB5?-Z=GAT1=W+\9ZN=XE]93
MEM&7X>FS1USSSRS^>11.:YE7F&(JO5]4<T<D?GE:E-DUP   >K8[+<\DO5HQ
MZRTKZZ\7VM@M]KHV?"EJ*F1(HF)]TYR(==Z[3:HFNKBB(UGHAV6K55VN**>.
M9G2.F73AHWIC:=']-\6P"T-B<VR4C?=*M8FRU==+Z=54.Z(J\\BKMOW-V;W(
M4#FF/JQV)KO5<L\7FCDCL7UEF IP.'ILT\F_SSRRV>:]G@     :<U^TOIM8
M=)<RP62*-U?<*)T^/3.Z=E<J;WVD?S>"+(U&N^U5R>)M,FS"<!BZ+W)$\?HS
MO_/.UF<8",=A:[7+,<7I1N<R4L4D$DD,T;X9H7*R6)Z*US7-7945%[E0OZ)U
M4-,:)9<$6GS=0.(;$$J84GMF&I+D]R:O_J'+YK_^ZDA^@C>UF-^2Y?7IOK\6
M.O?_ $ZI%LI@OE.84:[J?&GJW?U:.AXI%=0   <[/&_3QTO%'JG'%ORNEM,J
M[]?2FL]%([\KE+OV2G7*[7\WMU*4VKC3,[O5[%**)(T=    !U Z&TTE'HGH
M]1S<O:TN$8_#+R]4YF6V!J[?B//V;U<+&WI_^2KVI7[E,<'!V8_@I]F&TS7-
M@     !RC9)')#D5_AE8Z.6*XU3)(W=%:YLSD5%/1MB=;=/1#SO?C2Y5TR\0
M[74   &?Z40Q5.J6FU/,Q)(9\JL\<K/6UU;"BH8>8SIA;L_P5=TLS+HUQ-J/
MXZ>^'4J>>7H$  :WUAS/]3S2S4#-6N1M1CEBK:N@W[EJTB5M,W^5*K4,[+,+
M\JQ5NU]JJ.SE]3!S/%?)<+<N_9IGMY/6Y=7O?(]TDCG/>]5<][EW557O55/0
MB@'\@ )K>3^O%':^)+'Z>K6)KK[:;I;Z)[T[INP\X3955-E5L"I].WB13;2U
M->753'),3Z]/>E6QMR*,QIB>6)CU:^Y?\4PN,     "K;RE&DL5?CN,ZR6RE
M_9]AF98LHD8GPJ*H5SJ25_\ @IE5G^,3U%A;!YEP;E6%JW3XU/3&_MCCZE?[
M=9=PK=.*IWQXL]$[NR>+K4Z%H*R='O!]B[<3X;]+*+LU9-=+6M[J'*FRO6ZR
MOK&*O^+E:B>Q$*+VGQ'A\QNSS3P?N\7N7ALSA_ Y=:CGC7[W'[TES0MZ
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M=(GKYG]DU%^U<GK*SV]S#6:,-'I3W4^_U+)V$P&D5XF?1COGW>M:Z5RL0
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M\JM:OP2]-G,J_P!NPE-$^7/'5T\W5N4?M%FO^X8N:X\B.*GHY^O>C4;YH@
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MH=G+F65<*GQK4[IYO-5\>5;^S^T5O,J>#5XMV-\<_GCX<B7I&4E
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MS(CH=P     '+?J[^VQJ?^%MZ_3ICT+EG[+:]"GV8>?\R_:KOIU>U+79FL(
M  -U\-U/%4Z_Z,QS(KFMS&SRHF^WI15<<C?_ !-0U6>SI@+_ *%7<VN1QKC[
M/IT][II*"7P  (#>4=^Q]H_PMMOYBK)EL+](3Z$]\(?MQ^P1Z<=TJ)"X%1
M !F."Y_F.FF14F58-?Z_'KY2>BVKIG=)(U5%=%-&[=DC';)NUZ*B^HQL9@K.
M+M^#O4\*G\[N9DX3&7L)<\):JX-7YW\ZV[1;RC6(WYE)9=9;4N'7?9(URJW,
MDJ+7,[Y4L*<\]/O[.T;XJK4*TS78:[;UJPL\*/LSQ5=NZ?5UK(RO;>U<TIQ4
M<&?M1QT]F^/6L8QS)\<R^UP7S%;]:,CL]3]8N=MJ(ZF%WK3GC5R;IXIWIXD'
MOX>Y8JX%RF:9YIXDWL7[=^GA6ZHJCGCC>Z=+M
M            01X]M;OU-=+%PFR5O89?J6V2A;V:^^4]I:FU;-[.T14A;]TY
M6]6$PV-RGY7BO"U1XEOCZ:N2/?U>=$=L,U^287P5,^/<XNBGEGW=O,H9+B5
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M*USJ5VBR"O++O%QVJO)G^V?/W]JYMGL^IS.UQ\5RGRH_NCS=W8E>1Q(@
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ML7Y3&2N?_)-[LUA/E.86J9W1.OW>/W:-'M)BODV7W:HWS&GWN+WZN;HO51P
M    '2CPI6!N-\.>D%N:U&)48]!=-NG?=5=<%7IZ_."A]H[WA<QO3_%I]WQ?
M<O39VSX++[,?PZ_>\;WI!FE;D               YYN.R>6;BDU)CD=S,I8[
M+% FR>BU;/12;?SGJI=NQ\:97:_F]NI2VUTZYG=_E]BE$0DJ-@    ZO<?\
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M7;)S-5';)OL45FN67,NOS9KZIYXY)_/*O'*LSMYA8B[1UQS3S-M&M;$
M          Q[+,FM6&8QD&6WN9*>T8W;ZBXW"551/>J>-9%1N_>Y=MD3Q7H=
MV&L58B[3;HWU3IVNG$7Z;%NJY5NIC7L<O&=YA==0,SR?-KV]77/*+E47&J;S
M*Y(^V>KFQ-5?BQMV8WU(B'H3!X6G"V:;5.ZF-/STJ Q>)JQ-ZJ[5OJG5B9D,
M< O8\G?IG]1^C%3FM9!V=VU+KUJV*J;.2W4*OIZ1J]-^K^VD3UM>A4&V^/\
M#XSP4;K<:?S3QS[HZEN;%8#P&#\+.^Y/JCBCWSUI^$,3$     "B[RBNFGU)
MZQT.<T<'9VK4JWMGG>G1ONE;D93U+43VQ=B_VJYQ;VP^/\-@YLSOMS_3/''K
MU5+MM@? XN+L;KD?U1Q3ZM%?A-$,    !O/ANU0=I!K-A.9RS+%:(JQ*#)4\
M%MM;[S4.5/'LT=VJ)\IJ&HSW+_EV#KM<NFL>E''';NZVVR/'_(<91=Y-=)]&
M>*?CU.E]KFO:CFJCFN3=KDZHJ*4(O=_0       ')6>DGG(    $O.!.A;6<
M4&G;WI&YE!%>*E6/3?=4M54QNWM1ST7Z",[85\'++GGX/M0DNR-/"S.WYN%[
M,NA@I-=      %#?E%J9D'$/VK%>KJW&+9-*B]R.1]1%T^AB%Q;#U:Y?_//N
M5#MM3IF'\L>] \F"(     ZO<?\ [ V3^(4WYIIYQO>75TO1-GR(Z'KG6[
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MAFAD3F9)&]NZ*BHO12I[ENJW5--4:3"U;=RFY3%5,ZQ+[S@Y@
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MSIW)\)?9W)[5ZDAPN"IL\>^6CQ&+JN]#4YFL0
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M<MYZ%>?P    63>3*_;8S[\$E_3J8@FWW[+;]/\ ME.=@_VJYZ']T+KBJ%J
M  !39Y3UDR9KI8]4?YNZR5S8W?%YTJ6<^WMV5N_T%H_Z?_,W?2CN5CM]KX:U
MZ,]ZKXL%      >OC_\ 9ZR?Q^F_.M.N]Y%70[+/EQTNKT\XO1(
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MK^J4M*WI# SY$;?!/RKXDELV*;5.E+0W;U5V=98P=KJ
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M]J6J38M<   &\N&?[(+1O\+;9^?::C/_ */O^A/<VV1?M]GTX[W3$4(O<
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MRWY!C:[<>3/'3T3\)UCJ7EL]F/R[!T7)\J.*KICX\4]:1)I&[
M            &.9?E-GP?%[_ )?D%1YK9<;H9KA<9O'LX&*Y6M3Q<[;9J>*J
MB'?AL/7B+M-JC?5.CHQ.(HP]NJY7NIC5S&ZI:AWC5;4#*=0+[Z-=DM:^H;3<
MW.VG@39E/3L7INV&)K6)\Q?^78*C!8>BS1NICMGEGKGC4+F&-KQE^J]7OJGL
MCDCJCB8 9C#           !*?AWPKGDJLWKXO1BYJ2Q\WRE3:>5/F3T$_E&G
MS3$?\<=;:Y=9^O/4EB:5M@   P//\]M>!V9]=5JR>XU"*VTVS?9T\B>OU,;\
M9?\ ZJAD8;#3>JTC<Q\1?BU3JK]R#(+KE%UJ;S>:EU36U*]5[FL:GP6,;\5K
M?!/_ *DGM6J;=/!I1^Y<FN=9>*<W
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M0VTS#Y/@O!QY5SBZH\KW1UI=L;E_RC&>$GR;?'USY/OGJ7TE.+?
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M1+*B[^I^Z'GS-+/@<7=HYJZN]?\ E=WPN$M5\]%/<V48#.
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M-5>S@B3X,<:+X)^5>I*+-FFU3P81Z[=FY5K+&3M=0
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MU7 ?Q0TZL2+3VDKN;?=8+S:4Y?G[6KC_ "';3MAED_\ )I_+5\'75LAF<?\
M'_53\6/U?!AQ-T2S)-I1=7]@F[^PK+?4;]-_1[&J?S?1N=U.U665?\T=DQ[G
M35LOF5/_ !3VQ/O8O6<+_$-0_7]'<]?LQ7_L>@DJ.B?X'GZ^SO,BG:#+ZO\
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MG1Z/>=0    3,X!?LF\._B%X_0)B+;9?1E?33[4)1L?])4=%7LRZ""EER@
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ML&OUVAC5.2LPZX13I]JE712)^5B$+V[IUP$>G'=4F6PU6F.GT)[Z5ZA4*VP
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M^+J^K\.I. B25@  !Y&0?V!O?\0J?S3CLL^73TNN]Y$]#E"/1SSL    "7G
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ME.]ZK_@T('MW@/"8>F_&^B=)Z*OA.G:G6PV/\'B*K$_7C6.FG\->Q=852M,
M              YE>)"@?;M?M9J=_/O)F5YJDYDV7:JJY*A/R2="_<BKX6 L
M3_!3ZHT4/GE'!Q]Z/XZO7.K2IM6J    !T;<&^7QYEPXZ:57:\]38J!;!6Q[
M[K&ZU/=31-7YX61N^94*-VHPW@,QNQSSPOO<??JN[9C$^'R^U/-'!^[Q=VB3
MQ'V_    !#SCJSJ/"N';*Z5DB,N.;34^.6Y-^]*EW:U/3U>;0R)\ZH2?9#!_
M*,PHGDH\;LW>N81G:W%_)\OKCEK\7MW^J)<]Q=:F     ;EX=:I:/7S1B5&(
M_GS6QP;;[?7ZZ*+?Z.;<U>>4\+ 7_0J]F6TR2K3'6?3I[X=-Y0*^0
M    8?FV 89J/9)\<SG&[7DUGGWWI:R/F5CEZ<\,B;/B?ZG,<CD]9DX3&7L)
M7P[-4TSYOSQ];&Q6#LXJC@7:8JCS_GBZE+G%/P1W72&EK<]T[FKLDT[B=VET
MH)DYZ^SM<J^D]6I[]3I_=-D<WXZ*B*\M79W:RG'3%F_XMSDYJOA/FY>3F5;M
M!LI5@8F]9\:WR\]/QCS]O.K^)HAH   3^\F]!+-K_=)(V\S*7#KC+.NZ>BU:
MJBCW_G/1"&;=3I@(]..ZI,MAXUQ\^A/?2O6*@6V
M 5"^4@UL;55EFT.L54O9VYT5ZSAS%Z+,]N]#2.V^2QRS.1>GI1KWH69L+E.D
M3BZ^7BI_NGW=JMMN,UUF,)1R<=7NCW]BJ4L978           ,KPG%ZG,<EM
MMAI^9C*E_-63I^Y0,]*1_P"+N]NR'3B+T6J)J=MFUX2N*5DE'1TUOI*:@HX6
M4])1Q,AIH&]S&,3E:B?,B$4JF:IUE)(C2-(?2?'(  1AX@,^6D@;@]KFY:BK
M:V6_2L7JV%>K(/Y?PG>S;P<;?+,-K^LGJ:O,,1IXD=:(INVH
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MS8FKOXH4?M5COE685SR4^+'\N_UZKLV7P7R7 4<]7C3_ #;O5HE41U(0
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M&X/8(E794]**WP1O3KZG-5"@,[C3'W_^RKVI7UDLZX&Q_P!=/LPW :QLP
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MXAYU^4]M4[;V,]A:.P&*UM7;/-/"[>*>[UJQV]PNEVW>YXX/9Q^_U*NBP4
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M^58^K3=1XL=6_P!>JZ=E,#\EP%.N^OQIZ]WJT2Z(TD@
M   "G'RC^M+;M?;)HK8JQ'T..JR[YDL3NCJ^5BI2TSMO[C$Y9%3NWD;XM+0V
M%RK@458NN..KBIZ.6>N>+J\ZLMN,TX==.%HGBIXZNGDCJCCZU7)82OP
M      9[IMA[\URN@M3FO]SHE\YN\K?BT\?PDW\%>NS4^<QL7?\  VYGE=^&
ML^%KT6,1QLAC9%$QL<4349'&U-D:U.B(B$62-_8?0 !"_B"S);K?8,5HY=Z"
MP^G7(G<^L>G_ /&Q=OG5QOLLL<&GASOGN:7,+W"JX,<B.YM&N
M    /]1%<J-:BJJ]$1 -ZX3H1D>1)%77YSL<M3_2:V1N]7(GVL2[<F_K=_-4
MUV(S&BCBIXY]3/LX"JOCJXH2PQ7 L6PV%L=DMD4=1R\LMRE]\J9/7S2+W;^I
MNR>PTM[$UW?*EM;5BBWNAF1T.\     "'/$I(BY%CL.R[QVY[U7[N54_^TWN
M4^1/2TV9>5"-IM6M   #J,T<IF46D.E='%&L,=)A]CACB7?=K64$+43KUZ;>
M)Y[S2KA8N[/\=7M2O_+*>#A+4?P4^S#9!@LX
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MY_FEOA[_ (*-H:^7?_P;?2378.G7'U>:B?:I0S;FK3 T^>N.ZI1B6ZJ4
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M=745]54UU7*Z>JK)7S5,SN]SY%YG*OSJI+*8BF-(1J9UG5\Q]?
M    &8X?@N0YO6^:66DWAC5$K+C+Z-/ B_+=Z_8FZ^PZ+^(HLQK4[K-BJ[/$
MFC@FD>-84V*K[-+O?6IN^[5#4]!W]XCZI'\_5WM-!B<;7>XMT-U8PE%KSRVL
M8;+        (,\0E8E3J!V*+NMOMM-3N]FZOF_\ Y"1993I:ZVBS"=;O4T:;
M!@@  !U7X;3.HL0Q6CD<U[Z2ST,+W-[E6.G8U53\1YTQ57"NUSYY[WH;"T\&
MU1'FCN9*=#O                             (H<9VK*Z4:&Y%-05*P9+
MF7_H[CJM79['5;'><3MV5%3LH$>J.3N?R>LD>RV6_+<=3KY-/C3U;HZYTZM4
M=VHS'Y%@JM/*J\6.O?/5'KT<[1=ZE  !8[Y-C O=S57)\]J8E=28+9_-Z)^W
M=7755B:J+[*>.9%3[9"#;>8SP>%ILQ]>?53^.B<;#8/PF*JO3]2/75^&J[<J
M9:H             ##=0\.H=0L%R["+CR)293:JJW.E<G-V3IXU;'*B>N-^S
MT]J&5@L5.%OT7:=],Q/YZ6-C<-&)L5VI^M$PY;;K;*ZR72Y6:YP/I;E:*J:B
MN%*[X4<\#UCD8OS.:J'H6W<BY3%5.Z>/M>?KEN;=4TU;XXNQYYS<     >WC
M>0W7$LALF46.H6DO&/5T%PME0F_HS4[TD9OLJ=-TZIZCJOV:;]NJW7NJC2>M
MVV+U5FY3<IWTSK'4Z@--,[M>IN XGGMG5$H<HMT58D._-V,JIRSP.7Y44J.8
MOM0\^X_!U8._79JWTSI\)ZXXU^X'%TXNQ1>IW51K\8ZIXF<F(RP".7%Q6>8<
M-VKD_/*SGLGF^\??^R)HH=OF7GV7V&\V:IX68V?2[HU:3:2K@Y=>]'OG1S<%
M[*-    !LO1>L]SM8M)[A[W^P,RL51[XNS/>KA _TE]70P,UIX6#O1ST5>S+
M/RNK@XNU/-73[4.HD\^+^      YD>(NJ\\U\UGEY.SY,TO<'+OO]8K98M_#
MOY=R_LCIX. L>A3W0H;.ZM<=>].KOEIDVC5@    Z+.">K2MX7]*ID:YO)37
M*#9>OUBZ5D7_ -A1^U=/!S.]U>NFE=NRM7"RRUU^U*5!'4@    !6-Y3JX-C
MT_TSM7H<U9D-35(G7FVIJ56+MX?NY/\ 8"C_ -B[5_#WS^"!;>U_J+5/\7='
MXJ9"TU7@    G?Y.FI9!Q#]DYKE6MQBYPQJG@J/@EW7Z(R'[<4ZY?_/'O2_8
MFK3,.FF?<OE*=6\   $*/*!524_#5D<2L5WGUVM,*+O\':J;+O\ _#V)7L73
MKF5/15W(KME5IEU7GFGO4!%SJ<    !)3@_JDI.)72656*_GNTD.V^WU^EFB
MW^CFW-#M/3KEM[H]\-[LU5P<QL]/NET@%%KP       5U\7?!=3ZH.KM2-+Z
M>EM^H2,62]V!.6*GO:I^Z(Y51L=3MXKTD^-LOI+-]F=JIP>EC$<=ODGEI^-/
M<A.TFRT8S6_A^*YRQR5?">]2;<[9<K+<*RTWB@K;5=+=*Z"X6VKB=#/!*Q=G
M,DC>B.:Y%[T5"V;=RFY3%5,ZQ/*JNY;JMU335&DQR/A.3@     !NO#.(W7/
M3^*"FQ74_*Z&BI=DIK;43^?4D:-[D935B31(GL1IJL5D>!Q7'<M4S//NGMC2
M6UPN=XW#<5N[5$<V^.R=8;YMGE#>(V@B[.JN&(7MVVW;5MK8UWS_ +%? W\A
MIKFQ.75;HJCHGXZMO;VTS"G?-,],?#1]\WE&>(66)\;(L!IG.[IH[;*KF_-S
MU+F_C0X1L-E_\?;^#LG;?'S]CL_%IO,>+CB)SB.2GN^I]]HJ.1.5:.S=E:6<
MOBU74+(7N1?MG+^(VF%V:R_#\=-J)GS^-[6K5XK:3,,1Q579T\WB]VB.LT\U
M3-+45,TM143.5\T\CE<][EZJKG+U55-Y$1'%#23,SQR_(^OBW3R9>G*1T>H&
MJU;3^G4R1XU8)G-ZHR-&U5<K57P<KH$Z?)5/FK3;['<=O#QZ4]T>]9.P>"XK
MF(GT8[Y]RV KA8@    .>SC,T J-%M3:RY6BB<S3_.)I;AC,T;?>J65R\U1;
MUV3T>R<N[$_N:MZJJ.VNO9;.8S##135/ZRCBGS\U77R^=3&U&33@,3-5,?JZ
M^./-ST]7)YD/B3HR         /KH:&MNE;26VVTE37W"OF93T-#3L=)---([
ME9'&QNZN<Y5V1$.-=<41-54Z1#E11-<Q33&LROJX.N%>FT0L'U79=30U&J.1
MTR)6(O*]+12OV=YG$Y%5%>O197IX^BG1-W4YM1M%.8W/!V_FJ?ZIY_A'6N#9
MG9Z,OH\)<^=J_ICF^,J<>(RJ2LU]UGE1G)R9I>X-M]_K%;+%O]/+N6CD=/!P
M%CT*>Z%8YW5KCKWIU=\M,&T:L    '6/;:OS^W4%=RHSSVGBGY$7=$[1B.VW
M^D\WUT\&J8>BZ*N%3$OM.+D 1IXP,L;AW#CJC7(_EJ+K:_<.E8B[.>Z[2,HG
MHGS1RO=\R*;[9C#>'S&U'-/"^[Q]\-%M+B/ 9?=GGC@_>XNZ7."7HH\  9;A
MF>9EIW>8L@P?);MC-WBV3SNAE6/G:G7DE9\"1GK:]%1?48V*P=G%4<"[3%4>
M?\\3)PN,O86OAVJIIGS?GC6#:?>4NSRTPPT>H^$V7,6,1&K=[9*MKJU^WDCY
M)H7K]PV-"%8W8*Q7.MBN:?-/C1[I[TSP>W=^CBOT15YX\6??'<DW9?*1Z$U[
M(TNMEU"L,Z_7>UHJ:>)._P""^&J<Y?YB&@N["8ZGR9HGKF.^&^M;<X&KRHKC
MJCW2]Z?RB'#I%$Z2.KS.J>W;:".UJCEZ^'/(QOY3IC8C,9Y*>UW3MKE\?:[&
M@L_\IO3^;S4VEVG-1YR_ZQ>,GF:C6?/14;W<W^D)])N<%L!.NN(N=5/QG_%I
M\9M[&FF'M]=7PC_)6CJ/JEGFK5_?DF?Y'6Y!<ME92I)LR"FB5=^RIX&(D<3?
M8U.O>NZ]2>X'+[&!M\"S3I'KGIGE0/'9A?QM?#O5:SW=$<C7QFL, S?3O3O+
M=5,MM>%85:Y+I>[H_P!%O=%!$GUR>>3NCCC3JYR_,FZJB+B8['6L%:F[=G2F
M/SI'G9>"P5W&78M6HUJG\ZSYG1;H!H=CF@F 46(V;DK+K4*E7E60*W:2OKG-
MV<[V1L^#&SP;W[N5SEH[.LWN9E?FY5N^K'-'QYUV9-E-O+;$6Z=_UIYY^',W
M@:EM@                    %,OE&]:VW[)[1HQ8JSM+;B+FW++EC7T7W.:
M/]CP+Z^PA?S+]M)LO5A:>PV5>#MSBJXXZN*GT>6>N>[SJOVWS7PER,+1/%3Q
MU>ER1U1W^96*3] @           ;5TCP2?-<FB=-2RR6"R.CJ;Y/R[Q]=UA@
M<O=O*K53;Y*.V[C"QV)BS1_%.[W]C+PF'F[5KR1O_/G6!$:2!_H  !%3B0R9
M42RXE3R?"_Z1N2)],<#5_P#$NWS&YRJUOKZFIS*[NH12-RU0
M #>^F6B]?E?87K(.VMF.KL^&/X-16)]IO\%B_*\?B^M-=B\?%OQ:>.>YGX;!
M3<XZMR:%JM-MLE#!;+3104%#3)M#30ILB>U?6J^*KU7Q-!77-<ZRW5-,4QI#
MT3BY         "N'4RYI>,^RJM:O,SS]]/&[UMIMH&K^)A*L)1P;5,(WB:N%
M<F6"F0Z  !^D44DTD<,+'22RN1D4;>JN<Y=D1!,Z/L1JZRJ>"*E@@IH&\D%/
M&V*%FZKLUB;(FZ]>X\W3.LZR]%Q&D:/V/CZ
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M5]+F^%4K4=WQ?KW=]/B4QMI1P<RJGGBGNT]RX]C:^%EU,<TU=^OO38(HE0
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M_5RJY:@S?.K^9W.%<GBY*>2/Q\ZW,IR:QEMO@VXX^6KEG\/,WF:AM@
M              &L=9-3+9I!IKE>H-T[.1MAHW.MU$Y=O.JV7WNEI_7Z<KFH
MNW<W=W@9^5X"K'8FBS3RSV1RSV,#,\?3@</7>JY([9Y([7,=?;W<\EO5WR*]
MU<E?>+[63U]TK7_"EJ*AZR2/7YW.4O\ LVJ;5$44QI$1I'1"A;MVJ[7-=7',
MSK/3+RCL=8           +TM'>'9^G'"O<J&XT2,SK)88\KR!%;[["^%$DAH
M^[?>&GW:J?W1S]N\J7'Y[\IS:F8G]73XD=?%,]<^J(6M@\C^3935$Q^LJ\>>
MKDZH]<RT*2A%  !_@%;&>Y#]5.7WV](Y705-2K*+_ 1>]Q?C:U%)7AK7@[<4
MHU?N>$KF6'G>Z0            )4:3:*I*VER;,J;>-VTMLL,J=_BV2H1?#U
M,_G>HT^-Q_U*.WX-KA,%]:OL2O1$:B-:B(B=$1#2MJ_T/H         \7([O
M'8+!>+U*J(VV4<U0B+\9S&JK6_REV0[+5'#JBGG==RO@4S*L21[Y7ODD<KY)
M'*Y[U[U5>JJ2Y&'\   &3872)<,QQ.@7GVK;S00+R?"]\J&-Z>WJ=&*JX-FN
M>:F>YWX6GA7:(\\=[JN/.CT,                              *IF>3-
M?=KM<+SE&L<KY;E5RU533T5HYWJZ9_:.5:F:KZKU<FZQ^WV%C?I]P*(IMV=T
M<M7NBGWJ\_0/AU35<O;YY*??,^YGE#Y,W1J.)$N6;:FU<^R;R4T]NIV;[=?1
M?0S+W^TPJ]OL9]6BCUS_ '0S*=@\']:NOU1_;)7>3-T:DB5+;FVIM)/LNTE3
M/;JAF^W3T64,*]_M%&WV,^M11ZX_NDJV#P?U:Z_5/]L-6WSR7TR<TF-:OQ/^
M12W.SJWQ\9H:IWA_>S8VO]08^O9[*O=,>]K[NP,_4O=M/OU]RTS$,;HL-Q3&
ML2MJ(E!C%KI+71]-MXZ2%L+57VKR[J5YB;\W[M5RK?5,SVRL##6(L6J;=.ZF
M(CL9&=#O               (><6?"]4<1E)ALMGOMMQN^8K+5M=6U<3Y&S4M
M6UBNC][Z[M?$U4W];O62?9O:&,JFOA4S535IVQ_^HSM'D$YI%'!JBFJG7LG_
M /$4[?Y+N57(ZZZT1M:CNL-)85<KF[?+?7IMU^U4D=?^H/V;']7_ -4>HV ^
MU?\ Z?\ [,UH/)B8#'R^ZFIN85B\J\_FM+2TV[O!4Y^WV,2O_4"_]6U3VS/P
M95&P5CZUVKLB/BR:+R9^AZ1L2?+]5I)D3WQ\=9;6-5?8U;:[;\9T3M[C>2BW
MV5?YN^-A,%]NYVT_XOT_6T-"?WV:M?Z=;/\ RL^?I[COL6^RK_-]_03 _;N=
MM/\ @\JM\F5I*]9?<[/=1:5%3WCSAU!/RKMUYN2EAYOR'93M]B^6W1ZX]\NN
MK8/"\EROU3[H8?7^2]L<G/[EZQ76CW5.S\ZLL=3LGCOR5D&YE4?Z@U_6LQ][
M3^V6-7L!1]6]/W=?[H?1I_Y/W/-*]0<5SW$]7;)5U>,W-E5V4]LFI>WIM^6:
M%W)//MVT2N8[U(O><<;MI8QN'KLW+,^-'/KI/).Z-T\;[@]C;^#OT7K=Z/%G
MFTXN6-\[XXEII7BP0"/O$OHY===M-'8#:;W;\?EJ+K1UM3<:N)\S4AIN=5:Q
MC'-])55._IWFZR'-*<MQ/AJJ9JXIC3I:;/<LJS'#>!IJTXXGL0?M?DO*1O(Z
M]ZR5$VZIVD%%9&Q[)OU1))*U^^Z?:=/:2VY_J#/U;';5_P#5$[>P$?6O=E/_
M -F=T/DRM*(^R]TL^U#J]M^W\V6AI^;OVY>>FFY?RF)5M]BOJVZ/7/OAF4;!
MX7ZUROU1[I>O^MH:$_OLU:_TZV?^5G5^GN.^Q;[*O\W9^@F!^W<[:?\ !_CO
M)H:%\J\N6ZLH[;T56NMBIO\ -[F(/T]QWV+?95_F?H)@OMW.VG_!C5=Y,;3N
M1FULU*S2DDY5]*JIZ2H3F\%V8V#_ %G?1M_B/K6J?7'Q=%>P6'^K=J]4_!K^
M[>2]N#.9UBUCHZC??E@K[*Z';NVWDBK)=_'XB&=;_P!0:?KV>RK_ .L,*YL!
M5]2]VT__ &E;;1QS0TE+%4R]O410L9//\MZ-1'.^E2M:IB9XED4QI'&^DXOH
M    *C*'R8EXK9Y*S)-9:&&>>59:EE!9'3<ZN<JNV>^KA1N_W'T%EU_Z@44Q
MI18[:OPE6]&P5=4ZUWNRG\89W0>3%T^C1/=/4S,JQW+U6EIJ2F3F]>STGZ>S
M\IAU[?XCZMJGUS\&71L%8^M=J]4?%DS/)H:&(QJ29=JPY^R<[FUML:BKX[)[
MF+M^,Q_T]QWV+?95_FR/T$P7V[G;3_@_K];0T)_?9JU_IUL_\K'Z>X[[%OLJ
M_P S]!,#]NYVT_X/*KO)E:2R=I[FY[J+2;HG9><NH*C9?'?DI8=_R'91M]B_
MK6Z/7'OEUU[!X7ZMROU3[H8/=/)>V]_.ZR:QUM.J;K'#6V1DV_J17QUD6WS\
MJ_,9=O\ U!J^O9[*O_K+$N; 4_5O=M/_ -DSN%[1&[Z Z>7+!KOD%!DKIK_5
M72AKZ2%\")3SPT\:,>QZN]+FB<O?XHA%MH,VHS/$1>IIX/BQ'/QZS\4HR#*J
MLMP\VJJN%XTSS<6D?!(\T3>     @SQ.\(5XXC,\Q[(DS^BQ*R6.QMMJ4KK>
M^NG6?SB>:21&^<0,V5KV)W[]%]A+MG]IJ,JL54>#X54U:[].2(YI\Z)9]LU7
MFE^FOPG!IBG3=KQZSYX\S4EO\F%A4?+[K:IY36^EZ?FE#34N[=NY.=\^W4V=
M?^H%[ZMJGMF?@UM&P-GZUVKLB/BRFF\F=HFV/:LS+5*>7?X<-5;8F[?<NM\G
M^LQJMOL;R46^RK_)DQL)@^6NOMI_Q?1^MH:$_OLU:_TZV?\ E9\_3W'?8M]E
M7^;[^@F!^W<[:?\ !^4WDS]$'1/2GS#56*9?@225EMD:GSM2VL5?QGV-O<;R
MT6^RK_)\G83!<E=SMI_Q8S</)B8#(CO<K4[+Z-=DY5JJ6EJ=EWZ[\G8>!WT?
MZ@7_ *UJGMF/BZ*]@K'U;M79$_!D.B7 =<-%=8\2U(I=2Z7);5C_ +H><6R2
MV.HIWI64%32-1KDJ9VKRK,BKOMW'3FVV-.88.NQ-K@S5IQZZQQ51/-',[LJV
M0JP&+HOQ=X41KQ::;Z9CGGG6-$&3<   (K\57#Y>>(G&L4QJUY/;\8@L=V?<
MJZHJ:=]0LGO#H6(QK',ZISKWJ2+9W.J,JN5W*J9JUC3FY=4?VAR:O-+=%%-7
M!TG7GY$3;5Y+VU,2-;WK%<*IR]98J&S,@V]'N1\E7-OL[QY>J>"$DN?Z@U?4
MLQUU:^Z$<M[ 4_6O=E/XRSBA\F7I#'R^Z6=:D5>S-G^;24%/N_UISTDVR>S\
MIB5;?8OZMNCUS_=#+IV#PGUKE?JCW2]+];0T)_?9JU_IUL_\K.O]/<=]BWV5
M?YN?Z"8'[=SMI_P?Q+Y,_0Y8WI#E^J\<JI[V]]9;'M1?:U+:W?\ &?8V]QWV
M+?95_F3L)@OMW.VG_%B]P\F)@,B.]RM3LOHUV3E6JI:6IV7?KOR=AX'?1_J!
M?^M:I[9CXL>O8*Q]6[5V1/P8[:/)LWG%<JQO);%J];[C[@7:CN;*>LLSZ9W[
M%J&S<O,RKG15V;ZD^8[[NW=%ZU5;KLS&L3'%5KOC3FAT6]AJ[-VFNB]KI,3Q
MTZ;IZ96NE<K$         '\21QRQOBE8R2*1JMDC<F[7-7HJ*B]^XB="8U1"
MU1X']!M2GU-?!8)<#OU1NYUVQM6TL;GKUWDHW-=3KU[^5C7+\HDV7[6X["<7
M"X=/-5Q^O?ZT:S#9/ XOCX/ JYZ>+U;D"LY\FMJI9G2SX)E6,9K1M7WNEJN>
MU5R^K9C^U@7VJLR?-ZIEA-O,+<XKU%5$_>CW3ZD/Q>PN*HX[-=-<?=GWQZT4
M<IX:=?,-=-[O:39HR*F^OUE%2.N-,Q/6M10]O%M[>8D>'S[ 7_(O4]<\&>RK
M24=Q&18ZQY=FKJC6.V-8:9K:"NMM0^DN-'54%5']<IJB-T4B==NK7HB]Z&UI
MKBN-8G5JZJ)IG28T?(<G$  9MC&FVH>:OC9B.#9;DO:+LU]MM]14L^=7QL5J
M)U[U78Q,1C\/A_G+E-/3,0RK&!Q&(^;HJJZ(F4M, \GOKSEKX9\DI[)IY;'^
MD^6Z5#:BJ5OVE-2++U]DCV$;QNVN!L?-ZW)\W%';/NU23![&8Z]Y>E$>?CGL
MCWZ+"M)> C173E]+<\CIZC4W(:=4>E5>F-;;V/3QCMS%=&J>R9TOL(3F6V6-
MQ7BT?JZ?-O\ O?#1-,NV/P>%\:O]95Y]WW?CJFY##%3Q10011P00,2.&&-$:
MQC&ILUK6IT1$0B<SKQRE41IQ0_0^/H      #'LIQ/&LWL=;C676.VY#8KBW
MEJ[96QI+&[U.3?X+F][7)LJ+U144[L/B;F'KBY;JFFJ.6'3B,/;Q%$T7*8JI
MGDE5YJ_Y->.62INVBN3,I6NW?]1^0/<K&_:T]<QKG;>ILK%]LA866;>:>+BZ
M?YJ??3\.Q ,RV%U\;"U?RU>ZKX]JOO-^''7'3Q\J93IGE--30[\]TI*=:^BV
M3Q6JH^VB3=/6Y%)IA,]P.*^;NT]$\4]DZ2AF*R/&X7YRU5T[X[8UAI5['QO=
M'(US'L56O8Y-E14[T5#;-4_D !LW"]&-6-1'PMPO3W*[_#/MR7""CD;1IOW<
MU7(C8&[_ &ST,#%9KA<+\[<ICKX^S>S\+E>*Q7S5NJ>KB[=R>FD_DU\IN;Z6
MY:PY/38S0;HZ7&;(YE77O;XLDJE18(5^X27Z"&YEMY:H\7"T\*>>KBCLWSZD
MPR[8:[7XV)JX,<T<<]NZ/6M0TWTIT_TDL:8_I_C5!C]"[E=5RQHKZBID:FW:
M5$[U621WW2]/#9"N\=F.(QU?#O5<*?5'1'(L' Y=8P5' LTZ1ZYZ9Y6PS"9H
M!4=5>30R2^WJZW:]:O6:A6ZUU35R^:V>6I5.V<LG<ZIITWYEVV__  653M[;
MMT1339F=(T\K3W2K>K82Y<KFJJ]$:S]G7WPRRV^3"PZ+D]V-5LEKMMNT\SM]
M/2[].NW:25&W4QJ_]0+T^39ICIF9^#)HV!M1Y5V9Z(B/BR^G\F=HBV)$JLQU
M4FFZ\TD57;8V^ST5MSU_*8T[?8WDHM]E7^3)C83!<M=SMI_Q?M^MH:$_OLU:
M_P!.MG_E9\_3W'?8M]E7^;[^@F!^W<[:?\&,UWDQM.Y&;6S4K-*23E7TJJGI
M*A.;P79C8/\ 6=]&W^(^M:I]<?%T5[!8?ZMVKU3\&O[IY+RO9S.LNLE)4;\R
MLAK;(Z';Y*+)'6R[^U>5/F,VW_J#3]:QV5?_ %85S8"?JWNVG_[+.]+\4KL$
MTXP7"KE7PW2MQ*QT-GGN$+59'+YE V%'-:O5$V;XD S#$QB<1<NTQI%54SVS
MJGV P\X?#V[54ZS33$=D:,[,-E@ #\*BFIZRGFI*N"&JI:ECHZBFF:CXY&.3
M9S7-=NBHJ>"GVFJ:9UA\FF*HTE"O53@)T/U#=57&P455II?IU5_G5B1OF+G_
M &]O?[TC?9"L7SDKR[;+&X7BKGPE/\6_[V_MU1;,-C\%BN.B/!U?P[ON[NS1
M7WGWD[M=,66>HQ5^/:B6]BKV24%0E'6\B>+Z>L[-F_L9*]2:X/;? WN*YK;G
MS\<=L>^(0S&;%8VSQV]*X\W%/9/QE$G*=*=3<(=*F7:?YCCC(MU=45]NJ(85
M1.]S9G,Y')T[T78DN'S'#8CYNY35T3"-XC+L3A_G+=5/3$L ,QA@ #,<:T\S
MW,I(HL2PK*\E=,NT?N9;ZBJ3V[NB8Y$1/%5[C&OXVQ8^<KIIZ9B&38P5^_\
M-T55=$3*5> \ /$!F+X9KY:[3I];'JBNJ;U4M=4*SQ5E+2]L_F]DG)\Y',9M
MG@+'D3-<^;=VSIZM4BP>QV/O^5$41Y]_9&OKT6":3^3YT=P1]+<\SDK-3[[
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ML,3G-3=4:ZX0(J_0G4U^;U<'!7I_@J]F6PRFGA8RS'\=/M0Z@CSZOT
M
M
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M3JU&ILU$6.)NVR'3<Q^(N>7<JGIF9][NMX##V_)MTQT1$,W,1E
M           ,0N>G^!7J19;SA&(W:5SN99*VVTL[E=W;[R1N,FWC;]OR:ZHZ
M)F&-<P=BYY5%,],1+%4T%T,1Z2)HOI.CT7F1_P!3MLWW]>_FYD_[SCOW]S[]
M7Q8_^SX+]Q;^[3\&36_3G3VTR=K:L#PRV2[[]I26NDA=OW=[(T]9CUX[$5^5
M<JGKEWT8'#T>3;ICJAF2(B(B(FR)W(8K*?Z
M-8ZR:F6S2#37*]0;IV<C;#1N=;J)R[>=5LOO=+3^OTY7-1=NYN[O S\KP%6.
MQ-%FGEGLCEGL8&9X^G X>N]5R1VSR1VN8Z^WNYY+>KOD5[JY*^\7VLGK[I6O
M^%+45#UDD>OSN<I?]FU3:HBBF-(B-(Z(4+=NU7:YKJXYF=9Z9>4=CK
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M?Q\/>^OL-+M'7P<NO3_#W\3<[.T<+,+,?Q=W&Z4"AUZ
M
M
M
M         !3-Y1_65M\R>R:,V:I1]OQ%6W;*E8NZ.N4\:I3PK_@8)%=\\FW>
MTM/87*_!VJL55OJXJ?1C?/7/<J_;C-/"7*<+3NIXZO2G=V1WJQ"?H$
M     "=' 7HG^J9JNS,;Q3=IB>F3H;E,CV[LJ;FY56A@Z_(<Q9G=_P !J*GI
MD0VQS;Y)A?!4^7<XNBGZT^[K\R6[(95\KQ7A:O(M\?35]6/?U>=?84XN  \#
M*<>HLKQ^ZX]<-_-KG L:O3O8]/2C>GM:Y$4R,+B*L/=IN4[X8^*P].(M56ZM
MTJM;U:*ZP7:X66Y1+#76V=T%2SVM7O3UHO>GL+3LWJ;U$5T[I55>LU6:YHJW
MP\P[74@AKY=5N&H573([>.S4E/1L^=6]N[\LI(\MHX-G7G:''U:W>AI8SV$
M         &?Z<8/59WD4-M;SQ6VFVGO%8G[G"B_!1?E/[F_C[D4QL5B(LT:\
MO(R,-8F[5IR+#Z*BI+;1TU!0P1TM'1QMAIJ=G1K&-39$0B]54U3K*0Q$1&D/
MJ/CD           #56K^:?4=B=0M+*C+S>>:CM7RF[I[[,GW#5Z?;*TS,#A_
M"W/-#$QE[P='GE7X29'P    2YX%K>E?Q0:<*]&.CH&W:KD:Y53X%KJD9MMX
MH]S5(UM?7P<LN^?@^U"2;)4<+,[?FX7LRZ&RDET@
M
M
M
M    #76K.HELTGTYRW4&[(V2GQNA?/!2JO+YQ4O5(Z:!%_OLSFL^DSLMP-6-
MQ%%FGZT]D<L]4,+,<;3@L/7>J^K';/)'7+F*R/(+KE=_O637VJ?6WF_UL]PN
ME6[O?/4/61Z^SJO1/ O^Q9ILVXMT<44QI'4H2_>JO5S<KWS.L];Q3M=0
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MUQW3/N3#8BCA8^9YJ)[XCWKW"GUN@
M
M
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MY/JBJHU^,U=TID7V+U?_ #?E(;K+<)_R5=7Q:G'XGZD=:+!N&J      L_\
M)AVM9<XU1O7Q;?8J*B7YZRI=(GA_ZMZ__P"J_P#]0+FEBU3SU3/9'XI]L%;U
MO7:N:F([9_!<J5:L\
M
M
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MPW&X,2QJTV&#D5:*%/.96_ND[O2E?]+E7Z")W[OA:YJ26S;\'1%+)SJ=H
M        -%:P:J1XE226&R3LDR:M9M)*U=_,HW)\-WVZI\%/Y2^&^QP.#\+/
M"J\GO8&,Q7@XX,;^Y!Y[W2.<][G/>]5<][EW557O55)"T;^0      7&^3!M
M'8XCJO?^7K<KO;:#G]?F,$LNW?X>=^K_ /JK_P#4"[K=LT<T3/;,?!9NP-O2
MU=KYYB.R)^*T<KU8
M
M
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M^Y"*IJ:BMJ)ZNKGEJ:JI>LE142*KGO>Y=U<Y5[U4D$1$1I#23.K\#Z^
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MOG>,Q>-BW=N:TZ3S?!<,5BLP
M
M        !CV6U]5:<4R:Z43TCK;;::VJI)%1'(V6&![V+LO1>J'=AJ(KNTTS
MNF8[W3B:YHM551OB)[E#']7UQ-_OQM']#T'_  2X_P!#<L^Q/WI^*H/TPS+[
M<?=CX))<)G%GK?JMK?C>%9KD=ON./7&DN,M52Q6ZDIW.=3TDDL?OD4;7)LYJ
M>)H=I-F\%@L%5=M4S%43'+,[Y;S9S:/&XS&TVKM6M,Z\D1NA;L5HLD
M                                   !C>8Y5:,&Q7(<POTZ4]GQJ@GN
M%PDZ;\D#%=RMW[W.VY6IXJJ(=^%P]>(NTVJ-]4Z.C$XBG#VJKE>ZF-7,#J'F
M]XU)S?)\[OS^:ZY/7RUM1&B[MB:Y=HH6*OQ8HT:QOL1#T#@L)1A+%-FC=3&G
MX]>]0>-Q=>+O57J]]4Z_AU;F&F4Q0          ^R@H*RZU]%;+=32UEPN4\
M=+04<2<SY9IG(R-C4\5<Y41#C77%%,U5;H<J*)KF*8WRZ8M -)Z/1;2G%L$@
M2)UPHX/.LCK&?]8N=3L^I?OXHCO0;]HUI0>=9E.88JN]R<GFIC=\>E>^39=&
M PM-GEY?/5._\\S<QJVT       <MVKEA7%M5-2<<Y>1MDR>ZT<2)W=G#5R-
M8J=W16HBGH7++WAL+:KYZ*9]3S_F5GP.*N4<U4QZVO#-80       !85I%C'
MU+X/:H)8^SK[FGNA<$\>>=$5K5^Y8C47VD8QM[PEV>Q(<):\';ALXQ&4
M     /U@@GJIHJ>FAEJ*B=R,A@C:KWO<O1$:U.JJIQJJBF-9?::9JG2$3M3-
M=E_95APB56JBNBJ\B[E]3DID_P#O_F^#C=X3+OK7.SXM1B<=]6CM16>]\CWR
M2/=))(JN>]R[JJKWJJFY:I_         #I,X3+#]3?#AI#;^7E\XL,=TV^^L
MC[AO]/G!1&TE[PN8WI_BT^[XON7GLY9\%E]F/X=?O>-[TB#2-T
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M>?TXO)Z?9'VS[PW7\VTB.VWT=/I0EFQ?TC'HROR*;7"
M
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M9E9+0^/M*1TZ3W!/#S>'TY$7[I$Y?I,?%7?!6YEWX>WX2Y$+("*I(_T
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M
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MT6.QEN;5ZYK3/)I3&[HB)96#V?P.$N1=M6]*H\]4[^F92"-*W(
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M=U\2_P#*\!3@<-19IY(X_//+/:H3-,=5C<37>GEGLCDCL:P-@P
M ^JAHJNY5M);J""2JKJ^:.FHZ6--WR2RN1C&-3UJJ['&NJ*(FJ=T.5-,U3$1
MOETR: :3T>BVE.+8) D3KA1P>=9'6,_ZQ<ZG9]2_?Q1'>@W[1K2@\ZS*<PQ5
M=[DY/-3&[X]*]\FRZ,!A:;/+R^>J=_YYFYC5MH        59^4TP!]9CFGVI
ME)#NZR5D]@O+TZN[&L;V]*Y?4UCXI$^=Z%A[ XW@W+EB>6.%'5Q3WQV*_P!O
M,'PK=N_')/!GKXX[I[5.Y9ZL@      $K.&NPI_Z0Y/*SKZ%MHI/Q2S_ /\
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MH+M;JE.:GKZ.9D\,B>MLD:JU?H4TURW5;G@U1I/G;BBY3<CA4SK'F?><',
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MQLOGE'J-+SMMB>#\^,LD])'*ZF?OR)\79:N9>OBBKZB<4SX/9R>#]:YQ]O\
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M";[$99X?$S?J\FWN]*?A''V(5MKF7@,-%BGRKF_T8^,\7:H[+;5.
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M:.)FS4_&NZJJE[X# V\%9ILV]T>OGF?/*C<?CKF-O57KF^?5YH\T,",QA@
M       !<IY,C#W4>%ZCYU-%LM_NU-9Z)[N_L[;"LTBM]CG5:)\[?85;M_BN
M%>M6>:)G[TZ>Y9^P6&X-FY>YYT[/_P!6@%?I\
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M[(Y9\LQL55>3;\:>GZL=O'U(QM9F7R3!S3'E5^+'1]:>SBZW/J72ID
M     $]?)_:.-U U9?G%WI5EQS3%L=?'SM]"6[2JJ43/\5RNFZ=RM9OWD.VT
MS3Y+A/!4^5<XOY>7MW=J8;&Y9\IQ7A:O)M\?\W)V;^Q>^4\MT
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M9_)**VEQ?RG,+M7)$\&/Y>+\5X[-X7Y-E]JGEF.%][C_  20-$W@
M                           !!SRAGV.-R^_UJ_..);L3](QZ,HGMI]'S
MZ4*#BY5/)\>3B^R"K/P2N7Y^D(;MU]'QZ<=TICL/^WSZ$]\+W"GUN
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MW<C=^YK6IX%!YYCJL9C+ER=VND>C'%'YYU\9)@8P>#MVXWZ:STSQRW>:EM0
M! _RB.,6V\\/\M_J86>Z6(7N@JK95;)SHE7)YI-'S=_*Y)4<J>*M;ZB8;$8B
MJWC^!&ZJF=>KC]WK1#;7#TUX#ASOIJC3KXOST*&RXE0KA?)?RR+CFKT"O58H
M[E:7LC\$<^&I1R_3RH5C_J#'ZRS/FJ[X69L#/ZN]TT^]:>5VL$   .2L])/.
M0!>7Y/\ T)H\'T[BU4O5$Q<PU#@[2V2R-].CLJNWA8Q?#SG9)7*G>WLT\%*B
MVTSB<1B/D],^)1O\]7+V;NU;.QN41A\/\HJCQZ]WFIY.W?V+"2%)H  (N\6>
MA%!KAI;=::DH(I,ZQB&6XX37(GOJS,3FDH]TZJVI:WDV[N?D=\4D&S><59=B
MHF9_5U<57QZN[5H-H\HC,,-,1'ZRGCI^'7WZ.<Y45%5%394[T+R4BD=PG:FS
M:5ZZX1>G3K#9[S5ML.2-YN5BT5Q<V)7O]D,G)-_(-%M)@(QN!N4\L1PHZ:?C
M&L=;>;.X^<'CJ*N29X,]$_#?U.D4HI>(  Q_*\EM>&XQD&67J9(+3C=OJ+E<
M)/'LJ:-9'(F_>J[;(GBO0[L-8JOW*;=.^J=.UTXB_38MU7*MU,:]CF U%SJ]
MZF9ODV=Y#*LEUR:NDJYF<RN;"Q>D4#%7XD,:-C;[$0]!8'!T82Q39HW4Q^9Z
M]Z@L;BZ\7>JO5[ZI_,=6Y[6C>EUYUDU&QK3ZRN["6]3[U]P5O,VDHX4[2IJ'
M?<,1=D^,[9N_4Z<TS"C 8>J]5R>N>2';EF7UX[$4V:>7U1RRZ5,!P/%],\3L
M^%X?;8K78K+"D5/$W;GD=\>:9R(G/)(OI.<O>I0^,QEW%W9NW9UJG\Z1YEZX
M/!V\):BU:C2F/SK/G9B8K)  %<'E"=":+*L&_5AL5"QF580UD>1/B1$6LM#G
M<JN?\IU,]R.1?D*_?N;M.MBLXFS?^2USXE>[S5?CWZ(/MIE$7K'RFB/&HW^>
MG\.[5246PJI:AY,_4N>FOV;Z35M0Y:&Z4J9'887+Z+*FG5E/5M:GKEC?&[_%
ME=[>X")HHQ,;X\6>B>..SC[5@["8Z8KKP\[I\:.F.*>WB[%PA6*S  !Y&0?V
M!O?\0J?S3CLL^73TNN]Y$]#E"/1SSLEKP+_93Z7?Y;_V)7D;VO\ HN[_ "^W
M2D>R7TG:_F]BIT/E(KJ   "G[RH/]GM'OXA>?SM(6=_I]Y%[II]ZM-O_ "[/
M15[E5A8BO70_P+_8L:7?Y;_VW7E([7_2EW^7V*5U;)?1EK^;VZDM2-I&   '
M/OQ]?9-YC_$+/^@0ET[&_1E'35[4J:VP^DJ^BGV80S)2B[JFP#^T3"OO#;?T
M6,\[8SY^OTI[WH3!_,4>C'<RXQF2   &(Y__ &B9K]X;E^BR&3@_GZ/2CO8V
M,^8K]&>YRLGHEY[3,X!?LF\._B%X_0)B+;9?1E?33[4)1L?])4=%7LRZ""EE
MR@ "FWRE&JTURRK%]'[=4K[FXY3MOF1Q,7H^OJT<VF8]/7#!NY/\*6CL'ET4
MVJL35OJ\6.B-_;/<K';K,9JNTX:-U/C3TSN[([U7I8* +A?)TZ#T='9:G7;(
M:-LMTNKY[=@C9$W2"DC58JNK;O\ 'E>CHD7O1K7>#RL=N,XFJOY'1/%''5YY
MY(ZM_9S+,V)RB*:/E=<<<\5/1RSU[NWG6GE=K!  &D.(C2&WZV:4Y+AE1!$Z
M[]@ZNQ.L=T6GNE.URT[D=X(]=XW_ &CG&VR3,ZLOQ5-V-VZKSTSO^,>=JLZR
MVG,,+5:G?OI\U4;OA/F<STL4D$DD,T;X9H7*R6)Z*US7-7945%[E0OR)U41,
M:)L>3^S*7&.(BSV=97-HLZME?9JIOQ>>.+SV%RIZ^>FY47[;U*I$]M,+X;+Y
MJY:)B?=/>E6QN*\#F$4\E<3'OCN7\%,KB  ',;Q"WF6_ZZZOW.67MDDRZ[PT
M\G5/>*>KD@@[^O2-C2_\DM>"P-FG^"GMF-9]:A<ZN^$QUZK^.KU3I'J:]Q-]
MKCRG&I+YRK9&76C=>$=W>:I.SMM^B_$W\#-Q/"FU5P/*TG3ITXF%A^#X6GA;
MM8UZ->-U81/CDCCDA<Q\+VHZ)[%16JU4Z*BIX'G27H>'Z'P  %*''-P\YG4:
MU297IOIYEV2VO,[9#<+U)8;55UL4-S8]\$_/YM'(UJR,9'(N^V[G.7VK:^R.
M=V8P7@[]RFF:)TCA3$>+OC?UPJO:W);TXSPEBW55%4:SP8F?&W3NZI0U_4"U
MV_@5U:_]W+G_ ,N2G_><#^_M_?I^*,?[/COW%S[E7P=)V"3W6JP?#:F^PU--
M?*BQVZ6\T]0QT<T=4^FC69LC'[.:Y'[HJ+U12A\9%,7ZXH\GA3IT:\2\\'-4
MV:)K\K@QKTZ<;*S'9            .?/CCU;_5/UONUOM]6E1C.GK76"S<B[
MQOGB=O73IWHO--NS=.BM8U2ZMD<M^1X*)GRJ_&GH^K'9WRIG:S,OE>-F(\FC
MQ8_NGM[H0W)0C           ?W'')+(R*)CY)9'(V.-J;N<Y>B(B)W[B9T(C
M5TF\+VD,>BVCF,8M/3MAR*NC]U\P?TYG7*K:UTC'*G?V+4;"GL9N41M!F?\
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MIJ>"CIX*2EB9!34L;8J>!B;-8QB<K6HGJ1$//-54U3K+T#3$4QI#]SX^@
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M';K]!"=NL;X+!Q:C?7/JIXY]>B:;$8/PN+F[.ZB/75Q=VJ\HJ-;(
M                             @YY0S['&Y??ZU?G'$MV)^D8]&43VT^C
MY]*%!Q<JGD^/)Q?9!5GX)7+\_2$-VZ^CX]..Z4QV'_;Y]">^%[A3ZW
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M4W:HB(TCHAZ/]5EQ'?PO9;_G(_\ <.'Z-Y=^YI<_TBS#]]4?U67$=_"]EO\
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M61F/TK62;>DC756ZHB^WE3\1 /\ 4"?U%KTI[D]V"C]?=]&.]<T58M
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M2ROTBS#]]4?U67$=_"]EO^<C_P!P?HWEW[FD_2+,/WU1_59<1W\+V6_YR/\
MW!^C>7?N:3](LP_?5']5EQ'?PO9;_G(_]P?HWEW[FD_2+,/WU1_59<1W\+V6
M_P"<C_W!^C>7?N:3](LP_?5-"7&X5MWN%?=KE4R5EQN=1+5U]7)\.6:9ZOD>
M[VN<JJ;FBB**8IIW0T]=<UU355OEL#16J?1:R:2UL;6O?29G89F-=W*L=P@<
MB+^(PLUIX6#O1_!5[,LW*JN#C+,_QT^U#J'//B_@ !Y&0?V!O?\ $*G\TX[+
M/ET]+KO>1/0Y0CT<\[):\"_V4^EW^6_]B5Y&]K_HN[_+[=*1[)?2=K^;V*G0
M^4BNH   *?O*@_V>T>_B%Y_.TA9W^GWD7NFGWJTV_P#+L]%7N56%B*]=#_ O
M]BQI=_EO_;=>4CM?]*7?Y?8I75LE]&6OYO;J2U(VD8   <^_'U]DWF/\0L_Z
M!"73L;]&4=-7M2IK;#Z2KZ*?9A#,E*+NJ; /[1,*^\-M_18SSMC/GZ_2GO>A
M,'\Q1Z,=S+C&9(   8CG_P#:)FOWAN7Z+(9.#^?H]*.]C8SYBOT9[G*R>B7G
MM,S@%^R;P[^(7C] F(MME]&5]-/M0E&Q_P!)4=%7LRZ""EER@'G7>N2V6JYW
M)5B:EOI)JE72+LQ.R8K_ $EZ=.G4YVZ.'5%//+A<JX%,SS.3^22261\LKWR2
MR.5TDCEW<YR]5557OW/1\1H\ZS.K;6@-KBO.N.D-MG1JT]3F%F\X8[N=&RLB
M>]OTM38UN<W/!X&]5_!5W2V63V^'C;-/\=/>Z=SS^OL          (T<2_#9
MCG$/BT%'45#+'F-BYY,6R9(^?D5Z>E35")U=#(J)OMU:OI)XM=OLASZYE=W6
M..B?*CWQYVBSW([>:6M)XJXW3[I\RA;5/1;4G1J\.L^?8U6VI'2.9;[PQ%EM
M]8B?&IJIOH/Z=>7HY/C-1>A<F79KAL?1PK-6OFY8Z8_,*?S#*\1@*^#>IT\_
M)/1/YEJLV#7@&P<2U7U-P-6?4;GV78W''W4M#7SQ4Z^.SH$=V;D]BM,+$Y;A
ML3\[;IJZ8X^W>S,-F.)PWS5RJGHGB[$KL*\H?K[C2PQ9%)C.?4;/1D]TJ-M+
M4\J?(FH>P;O[7QN]O7J1S%[$8"[Y'"HGS3K'95KWPD>%VUQUKR]*X\\:3VQI
MW2FKIQY1W23)GP46>V6^:<UTJ[+6+_TI;D^>:!C)F[_X#9/%Q%,=L+B[/'9J
MBY'W:NR>+UI3@=M\+=XKT31/WH]7'ZD\\<R?',PM--?L5OMIR*RU?];W.W3L
MJ(7*G>G/&JINGBG>GB0Z_A[EBK@7*9IJYIXDPL7[=^GAVZHJCGCC>Z=+M
M        !2?Y1[5CZH]0;)I5;*GGM>!0)67QC%]%]UKF(YK7>"]C3JW;U+(]
M"U]A<M\%AZL15OKXH]&/C/="J]N,Q\+?IP].ZCCGTI^$=\JVR=H,
M   #HOX/M'5T<T6L%ON-'YKEF4_].Y9S)M(R>I:G8TSM^J=A#RL5.[GYU3O*
M.VGS3Y?C:IIGQ*?%IZM\]<^K1=NS66?(<'3$QX]7C5=>Z.J/7JE*1Y(
M          "'_&!PVT^O&$>Z%B@@BU)Q*-\V-52[-\\A^%+;Y7>I_?&J_!?X
MHUSR3[,9[.6WM*_FJM_F_B^/FZD:VER.,QLZT?.4[O/_  _#S];GSJZ6IH:J
MIH:VGFI*RCE?!5TLS59)%+&O*]CVKU16JFRHI=5-451K&Y3%5,TSI.]\Y]?
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MV=JG^$*9VSQWRC'S1&ZW'!Z]\_#J7%L=@?D^!BN=]<\+JW1\>M-PB:5@
M                                "#GE#/L<;E]_K5^<<2W8GZ1CT91/
M;3Z/GTH4'%RJ>3X\G%]D%6?@E<OS](0W;KZ/CTX[I3'8?]OGT)[X7N%/K<
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M0T6T&U%.:6(M1;X.E7"WZ\DQS1SMYD&S%65WYNS<X6M.F[3EB>?S)Y$.2\
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M*IJJWS.L],K^MVXMTQ33NCB['H'!S
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MD>3/VHYO2[^G?5>U>SGR:9Q-B/$GRH^S//Z/=T*VB=H,
M       +5_)JZ2NJ;EE6LUTIE["W,=C^)N>G1T\J-DK9F_<,Y(T7N]-Z=Z%=
M;>9EI31A:>7QJO='OZH6'L+EVM5>*JY/%I]\^[KE;Z5DLH
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MU>?YW*OB7CLI;HHRVUP>76>O6=?@I+:FY77F-WA<FD=6D:?%%DD*/@
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MWV* S+'58W$5WJOK3V1R1U0OO+L%3@L/19I^K';/+/7+8Q@LT
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M ?UY7/M[9G:>,?'@;W%=C^O\>>.N/-4FTNS4X&?#6>.U/]'X<T]4^> Y,D/
M                   M?\G/H.^:IKM=\DHE2"F[:V:?1RM^'(N\=;7-W\&I
MO Q?6LOR4*XVYSC2(P=$^>OW4^^>I8NQ.4:S.+KCS4>^KW=JW4K19
M                                 (.>4,^QQN7W^M7YQQ+=B?I&/1E$
M]M/H^?2A0<7*IY/CR<7V059^"5R_/TA#=NOH^/3CNE,=A_V^?0GOA>X4^MP
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MJJ1[8O$W<7CKUZY.M4T\?;"0[98:UA<#9LVXTB*O=*H4LQ6KH?X%_L6-+O\
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M&_B7=J]44OK+<PMX^Q3>M[I]4\L2HK,<!<P-^JS<WQZXY)AK<SF"
M;(TATZN&K.I6'Z?6Y9(Y,DN#(:RJ8B*M/2,WEJY]EZ>]0L>[;QVV,',\=3@L
M-7>GZL=L\D=<L[+<%5C<119CZT]D<L]4.GFS6BW8_:+78;12QT5JLM)#0VRC
MCZ-B@IV)'&Q/F:U$//UV[5=KFNK?,ZSTRORU;IMT113NB-(ZGIG!S
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M2B;]^N_7-RN=:IG65Y6+-%FB+=$:4QQ0]HZG:
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MU6ZFI)')]N^)C7.^E37XC'8C$?.W*JNF9EL,/@</A_FJ*:>B(AFIBLH
M      'B9!C6.Y9;9K-E%BL^1VFH^O6RY4T55 [VK'*US3MLW[EFKA6ZIIGG
MCB=5ZQ;O4\&Y3%4<T\:*N3<!_#9D<LE1#B%PQF>7J]]FN%1"S?[6&9TT3?Y+
M$0D>'VPS*UQ</A=,1W\4H]?V0RZ[Q\#@]$S^,,';Y-_A_221ZW+4AS7HU&PK
M<:7E9MONJ;42+U\=U7V&7^G6/YJ.R?\ )B?H/@.>OMC_ !9_C/ KPUXW+'4/
MPFIR.IBVY);S7U-0WIZX6/CA=O\ ;,4PK^U^97>+A\'HB(]>_P!;,L;)9=:X
M^!PNF9GU;O4E)8,;Q[%+=%9\7L-FQRTP=8;9;*:*DIVJO>J1PM:W\A'KU^Y>
MJX5RJ:IYYG6?6D%FQ;LT\&W3%,<T<4/:.IV@     ?R]C)&.CD:U['HK7L<F
MZ*B]Z*@$>LPX4>'G.99JF^:6X[%63[K)6VKM;5(KU^.[S!\".=]TB^TW>%VC
MS##\5%V=//XWM:M+B=G<!B..NU&OF\7V=&F*SR=7#O4S++"W.;<Q?^K4]S:K
M$ZJO[M!*[V=YM:=N,PB/JSU?"6KJV)R^9^M'7\8?!3>3?X?X&M;+<M2*Q6NW
M5\UQI454W[E[.B8ASJVZQ\\E'9/^3A&P^ CEK[8_Q;*QK@@X:L:ECJ&Z?-OE
M5&N[9KS6U58WZ8'2I OTQF!?VMS*[Q>$TZ(B/7O];.L;*9=:X_!Z],S/JW>I
M)ZRV*QXW;XK3CMFM5AM=/]8MMNIXZ6G9]S%$UK4_$1^[>KNU<*N9F>>>.6_M
M6J+5/!HB(CFCBAZIUNP            "*/%APW6[7_">:VQT]'J)C+))L2NK
MMF)-NF[Z"H>O[G+X*OP'[.[E>CI'LYGM667O&^;J\J/[H\\>N.I'=HLCIS*S
MXOSE/DS_ &SYI]4];GJN]IN=@NEQLEYH:BVW:TU$E)<K?.WEEAFB<K7L>GK1
M4+LMW*;E,5TSK$[E+W+=5NJ::HTF-[SCFX       +>?)JZ1^;T&5:T76FVE
MN*NQ[$5>G[A&YLE=.W?IZ3T9&U4[N21/$K/;S,M:J,+3R>-5_;'?/7"RMA<M
MTIKQ57+XM/\ =/='5*ULKE88                         *W>)S@.L^>O
MN&<:/14&-YC+SSW/%5VAMUSD[U="OP::9W^;<O?R+NY9UD&V%>&TM8KQJ.2K
MEI^,>OIW(/GVR%&)UNX;Q:^6GDJ^$^KHWJ:,BQN_XC>J_'<GM%?8KY:Y%AK[
M761K%+&Y/6U?!>]%3HJ=4Z%IV+]N_1%=N=:9Y85??L5V*YHN1I5')+Q#M=0
M            #,<!P/*-3,LL^%X?;9;I?;U,D5/$W?DC;\>:9R(O)'&GI.<O
M<AC8S&6L):F[=G2F/SI'G9.#P=S%W8M6HUJG\ZSYG1=P^:%8YH%@5+BMH5E?
M>:SEJLLR)6<LE=6<NRKZTBC^#&WP3[97*M&YUG%S,[_A*N*/JQS1\>==V391
M;RVQX.GCGZT\\_#F;U-0VP
M
M          <E9Z2><DGN#+[)O2?^/U?Z!4D?VI^C+W1'M0W^R_TE:Z9]F71L
M4:NX
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MW4\WGGGG\PN/),CLY9;TIXZYWU<_FCFA(XT;=@
M
M                           Y*STD\Y)/<&7V3>D_\?J_T"I(_M3]&7NB
M/:AO]E_I*UTS[,NC8HU=P
M                                                        *L^-
MWA"=?FW+672VU.DOK-Y\YQ2DC3]F,1%5]PIF-ZK,G[JQ/KGPT]-%Y[#V3VF\
M'IA<1/B_5JGD_AGS<W-NW;J_VKV:\)KBL/'C?6IY_P"*//S\^_?OIW+/5D
M  "R'R<>DOU3:AWK5.Z4B26G (/-;(^1/1?=JUBMYF[ILO80<RKZE>Q2"[<Y
MEX+#TX>G?7O]&/C/=*<;$9=X7$3B*HXJ-WI3\([X79E3K5
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M[-.D?G?SLX,1E@
M
M    <E9Z2><DGN#+[)O2?^/U?Z!4D?VI^C+W1'M0W^R_TE:Z9]F71L4:NX
M
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M:+ZY%C:BO7VNW4C&)QE[$SPKM<U3YYU2;#82SAHX-JB*8\T:,L,9D
M
M
M
M                            JBXR^"Y]>^YZMZ.V=SZ]ZNJ<RP:BCW6=
M5ZOK:")OQ_&2)OPOA-]+='6-LMM5P=,-BIXOJU3R>:KW3VJ[VGV6X6N)PT<?
MUJ8[Z??'8J)5%1514V5.]"S%;/\  )><$FE'ZJ&NEAFKJ99L=P1$R.]*J>@Y
M],]/,X57N].H5JJGBUKB,[69C\CP-6GE5^+'7OGL]>B2[*9=\KQM.ODT>-/5
MN]?O=#!2:Z
M
M
M
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MZOJ_'K3G(@EH
M
M
M
M                                 C=K/PIZ/ZY5<-VRNTUMJR.+D23)
M[')'25L\;.B1SJ^.6.5-DV17L5R)T:Y#>Y5M'C,NC@VYUIYJN..K=IVM'FFS
MV$S&>%<C2KGIXIZ]^J0]#14EMHJ2W4$$=+0T$,=-1TL:;,CBB:C&,:GJ1$V-
M)75-<S,[Y;JFF*8B(W0^HXN0
M
M
M
M
M
M
M
M
M
M
M
M
5                        ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.19.3.a.u2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>97</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="form8-k1720.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001000 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amicustherapeutics.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="form8-k1720.htm">form8-k1720.htm</File>
    <File>exhibit99117.htm</File>
    <File>fold-20200107.xsd</File>
    <File>fold-20200107_cal.xml</File>
    <File>fold-20200107_def.xml</File>
    <File>fold-20200107_lab.xml</File>
    <File>fold-20200107_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
M-(X'P"J8%EQV^3O8:W7..7AKQ%/25V^9"CGIYFHQ*/B76_..7+8\#?NW_+""
MWTG] E!+ P04    "  M."=0RP[)^^X    K @  $0   &1O8U!R;W!S+V-O
M<F4N>&ULS9+/:L,P#(=?9?B>R$YA!9/FLK%3"X,5-G8SMMJ:Q7^P-9*^_9RL
M31G; ^QHZ>=/GT"MCE*'A,\I1$QD,=^-KO=9ZKAA)Z(H ;(^H5.Y+@E?FH>0
MG*+R3$>(2G^H(T+#^3TX)&44*9B 55R(K&N-ECJAHI N>*,7?/Q,_0PS&K!'
MAYXRB%H ZZ:)\3SV+=P $XPPN?Q=0+,0Y^J?V+D#[)(<LUU2PS#4PVK.E1T$
MO.VV+_.ZE?69E-=8?F4KZ1QQPZZ37U</C_LGUC6\X147%5_O^5IR(47S/KG^
M\+L)NV#LP?YCXZM@U\*ON^B^ %!+ P04    "  M."=0F5R<(Q &  "<)P
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M(%;3/;-7!<O^61UZU.=O4$L#!!0    ( "TX)U"ZH3F*UP$  #(&   -
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M;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ +3@G4,L.R?ON    *P(  !$
M             ( !F0$  &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @
M+3@G4)E<G",0!@  G"<  !,              ( !M@(  'AL+W1H96UE+W1H
M96UE,2YX;6Q02P$"% ,4    "  M."=04[A14: "  "8"P  &
M    @ 'W"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @
M+3@G4*<<R M- @  V@4  !0              ( !S0L  'AL+W-H87)E9%-T
M<FEN9W,N>&UL4$L! A0#%     @ +3@G4+JA.8K7 0  ,@8   T
M     ( !3 X  'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  M."=0+6VE:#H!
M   G @  #P              @ %.$   >&PO=V]R:V)O;VLN>&UL4$L! A0#
M%     @ +3@G4/_ )@B]    A0(  !H              ( !M1$  'AL+U]R
M96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ +3@G4 N/V ,A 0
M5P0  !,              ( !JA(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
2      H "@"  @  _!,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6629491952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Jan. 07, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover page.</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan.  07,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AMICUS THERAPEUTICS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33497<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">71-0869350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1 Cedar Brook Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Cranbury<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">08512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">609<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">662-2000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of each class</a></td>
<td class="text">Common Stock Par Value $0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">FOLD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001178879<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>13
<FILENAME>0001178879-20-000002-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001178879-20-000002-xbrl.zip
M4$L#!!0    ( "TX)U"!$1JR=A$  /1;   0    97AH:6)I=#DY,3$W+FAT
M;>U<:W/;MM+^W/X*''=.QYZ19$G.S9=FCGS):=I<5,>9O.<C1((BCDF" 4'+
M.K_^?79!4I2L7.RX=9HX,W4ED006B]UGGUVL=/"/X]='9_\9GXC8I8D8OSU\
M\?Q(;'2WM]_M'&UO'Y\=BU_/7KX0#WK]@3BS,BNTTR:3R?;VR:L-L1$[E^]M
M;\]FL]YLIV?L=/OL=)N&>K"=&%.H7NC"C:<_'M!'3W_\X2!6,L3_?SCX1[<K
MCDU0IBIS(K!*.A6*LM#95+P+57$N!J+;;>X\,OG<ZFGLQ+ _[(MWQI[K"UG?
MX;1+U-.3RUA/M#O8]F\QV78UV\'$A/.G!Z&^$(6;)^J7C<ADKAO)5"?SO3.=
MJD*\4C-Q:E*9[?.U0O]/[0WZN=LGZ?'DTP,I,IGBV>+Q8'C\<'3X:'2R^V0T
M.-[M'^V</#[I/WKX['#WX?#ADXVG!]L2__%3]9]ZYD1GJALK6LO>8*?_S_U<
MAB%6W9T8YTQ*<U[N.W7INC+1TVPO41')<*#3J2AL\,N&\LO<W1WH5$[50 YV
M>__-IQM")NXC5ZOIJYD?/,$L,QVZ>&_P8(C7&[6\+:DGMO5VK?Q#R-^2-<!>
M*MM6X!-6X %]LD[U(ZMELN9^GID^OA,!^.W,SS Q28@!1JD.RD*<Q<K*7)5.
M!X486W.A8:KB;1[">@MA,G$$Z70@DXXX5=,RD<[8N9!9*%[*K(QDX$I+%CX*
M+V06*++]0D3&BM%9]]^C$;\<FS17XE@72A;JEK0PN*86!K>]#3<1P+^EF_>T
MP\#!NHT9#'?$6#K-FCS)K$D2X(C.Q#B&^@0NGKX>G[P0;UP9SL7//ST9#@;[
MU8T,/4=0=Z*<?^C!'\/^8/=>Z9]0.NE,9G,Q3A /A#-BE.?)G*V7;/UYAA@!
MCQ 2B)HD9/"'VB1F2E[S0D-0[ P] D^A8"(V#U^,MMI^@*U@G)]I%\-90HXY
MPD3B69DDC9/!QXHRP;[C]L&O>&! LKPI\]Q8YV_%+/!2W%IFH;+BF2P<1;'@
M7!RK EKC^>_W^Q/[#:1+-8?FYUD&=3I]H<1+%>H \HG-\?.76VU]BN=%4<*A
M)G-Q:+%U12Q>_GHZ\KLY-@Z"0Q+>[Q-I83BC(%!%T4*_QJ.QLV]A31CL=TP?
MFE0<PJU#@EKOX,/:".XW\1.;N'#!Y5C$N_*N_#_=<E*HUWN)W[+Q'^*TA*=+
MALM4V8#V[PU<4 EQHW4SJ[D[M:].W[_F]/TOF_Z_9>%T-&^/.+R!!.N0^73T
MZO#MZ7\ZXM5O'?&;S'KB<8>QM!;TFFO\^:>=X7X=-M>QH,U7L@CE^SWQ[/6+
MXZT.,'^:F DQH-P[<3<DH&!Z/]%P_B#.R,SF(JBB2(0LH/+I4!>!N5!DEQT1
MJ@N5F)QLE*)*J!+M+PE@D$I$6@&0!PXKK<)'3D(3.J"1B#\5G4^M6V=8C797
M]X)7?D.M.1-*XGV9*4'S0A$TM- NT\)TR17E>EK8$9JA\$+!;*;2YU_"\2[,
M6ZA9K;FW_%9H.&XFJG5"F&1>F *93D)W&$MQ,9"\ Q,22JCL?_,4CZL(ZE59
M,,=4\/P$N10'>QD@:Z-%5#%YFLP#,U4(X_6,13DIG,66;Q& !RI)"EXM) EB
M"6 !YD%;/&&!7::=*XL :#)3\CRC6,!3SHPM0!8$F81P2--ZM^5N=^_P-Y/@
M-Q-GXEE/'%DS2]2\(XYBJ2VLB/5[%&L5B9-+%90<HE]'V$*H#INTSG4+1U[9
M858\[.^_+J%D)5/V]L?[A5 1;,OQGD]\VN+9&=D N%5>!VGX91-(O.E)"\,/
MR41I#Q,X !:BLU)Q#)$B-63C!@+E,E L.S\]I3H /BL*V%9/O%/B/#,S;PQD
M[[4QEW9*W#U3L"&R_TS-.K DS!)V<05K9./T+J(KA,B5 =-?DO:J*Q0=H8I<
M48 #,:$\8MFUVFD=9@IH<,TSB;>]-SU>BA>9/OB]UQ&QQ$Y8R#;-V.;I2@PK
MP?"ACB(L*F.VO$ )@7128CF.1Z/[*[TL4:?%9J1*L7I$4%H:#2.7&:#0(R1N
M)ST55Q:#1[!-T[B:0=(.3<E6#C';>7WQK(*9-K^KQ?HX+VP]0;A'6J4;DGFO
MMD925%[G$'(IA]"+',)6.010!;,5%>K0_)4*D#TL[0'VA_ BAJW,E;0]6D-!
M@-;(@UUV@"RR#V\(]*RMLHD(J_++JQAFP;ECO6@2.BK).E2=;E8Y9JXO#.B7
MOQ_V6"4B!G[EX1!!CQ;J4;Z67A;B?:F#<PR(E[G!"B>$A+58BUTG/X0=I<K+
MH6;DP5DH;4@*"2@ LOK(-V')6.8:UZPMF9U^L/_Y< :PBJ];$/IFD/<*U>(I
M0NR&AYH]SB])$"H6!<#A"]@%IZ"M6@-V:5U9XFY#RK'G'F12$4P5AO*^E-;Y
ML$'ED$[MKD%3*B%?4)<!8 5OJCA0N0,OM/)&SP17U]S G/>K-?R%4(T<"0(\
MW&W=KZG*QGC:N![5?YI Y.<#P'SO-*'2- 5+\7 (PU7GX-.F!+!T)Y @!%W.
MD$US0/+;X-&1XA,0JB@\!U/$ :#[@.!,1LI5,&@2!(6)3C0^('+AD8P)O?5#
MM,+1%91"DI!,DS(PA0[),F02R4Z+>5J%H.!I<,-R-T].SYA-RI!!VH=O8&H7
M,(=0MQS9-E^\'A]O,?#75N=7J2D, D_#I84"J4%(C?WP<JX*3+),#(2 8**
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MX7^HW_ /8/]XP+_,_?3_ 5!+ P04    "  M."=0'\_TX%0#   $$@  $0
M &9O;&0M,C R,# Q,#<N>'-DS9A;3]LP%,??^11>WMTD(,9:T:(-AH3$V 1#
M\#:YSDEKD=B9[?3R[6>["4DO0).@B3?[Y/R._\=WY_1LD29H!E(QP8=>V L\
M!)R*B/')T+N_PU_OSJ^NO+/1P>DGC!^_W5ZC"T'S%+A&YQ*(A@C-F9ZBAPC4
M$XJE2-&#D$]L1C!>0<@5%BH:*#J%E""BM63C7,.ED.D%Q"1/]-#+^=^<)"QF
M$!D)"=@FUAQJGS61$] W) 65$0I#;ZIU-O#]^7S>(RFCN=)3D"2#7#.J>E2D
M_F%P& 1A<.(ADS!7@U@D41LN8?QIC5N,9=(3<F(\@R/??AX3!:7[8LM_?N2\
MPWZ_[[NOSZXJVN5HF_<??US?N<[S1@<(N<YD:2:D1GRK$V*BQHY44F.]S$"9
M&&$?!R$^"CVT&H1K08EV0UY0+HTZZB ?$JVJ0+@*U#,:/.0WD_,>0KI(R!6>
M$)(UEU$'5U(*2U<Y4B1MQF>G'A>KJZ"6$V:GH-9S9GM=,:XTX11>E+.-V!HN
M.6Q-.#SLIJ):W<U4E-Q[J.C[1%([U&;8J,:PR!+"B19R>6GJ^RE+I%R+\KT*
M8B7VK<3P<P>)+C*'B3T?]I=4I]Y51X-N*8G.[4=:^G8!^%QPS,V)*1G=3T:=
MO%F![ZBFG9+V,NH#<NQJT9[#40-LP\?-FE1 >Q,Q\ZG(N99+NS.=O+:EJ=?
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MO[&5%8;:AK>RK#;4T<$_4$L#!!0    ( "TX)U"7E3/=00$  ( "   5
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M]S1].UM>O]E;ZLZZ%L3#YK[_!AZ'HX_OZM_,U_\-RL=W_P=02P,$%     @
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MF?-PXQ'?S/OS6^[#:FY3NV+NYMM-_6F]O)SM.%:%-;9>56YVLBB_3N<N"XQ
MT5Q,FHL)@(\9Z[=P*]DN**^KVJ>S^FG1O/'W=!P62'8PB;!8T4@R&,><H(C$
M$J-86\(DEXQ*^MSRO,F[I7\DJE/3GPJ$J[#0 <M_A"0:,H0MDR16FC C8\Q0
MS"6UEFEL1?0:PW^,L?2S4>GGSH=Z9CP*G]PX[Q_3RY$*8!OG>N>+FOK9CE*>
M#WQ$3->I#R9,9LLLGS^-;@JBU@$K.R$NF-EGM+^E%ATVCW\(^S-LH@U"#!'*
M:(R(('$L%=<4(J$8QX#8%O%'0XU_&P9[$H(IZJR^_^066>-?47](5X=TL ^:
MF&!]I*V.F B*ED@&%?,H1I9+R6+61@9X:#+H@,!>57 6CI!^7?IM($+!5CM5
MWA:UOU?E_+@HCHY,HN 'P19*IF*"2,0ADBIL>,)"38B1+302#5,C7?+9JV1L
MEKL/MZMKYX_JXSLLP9A9JV(A.; D(C 8'4O!)>18687;U UDF&+X:?)ZC?Q5
MNCF;!P:RF^RA%_0*&1P8DU!HL%" Q"9BA((F'P+ )(H4(USS-AL$':8FNF&R
M5X'(^3R$I'I\"T<X!X^*8P\^X5;'2EJJ*56$:"@D%)1(;!2U"$C20AALF,)H
MS^*O$(4*EQ_]57E7O$82W]'!%2NA%1@);(B*: P%AQ1*#6-*H38M!,$'+8B?
MYO!7R&%;X7ST%[[\FC7-]E=HXL60)*S #-'-T=H2"&ULN;*2(0VH-=JV$888
MM##:$?DKU'%15G6:_YVM__$8LF] (@U%VN!(!0\(0E@@Q:U"/!*46P-QFT85
M&+0TVO#8DS":;4QZEQZ1PH^0A!*J&:2$0,Q(*)$%)E8;@#C04A#3ICT!!]>F
M;,%<3^%NGC/G%\NR.'[(? E+<$S"9#0&%@3ON1$H,"&#_\A*#:*X3=@'UYUL
MR5Y/H?_LL[IVA2I7J]OB\9!3'8C_7FP2D8ABPQE!H>KEH0+&2B"@++!( 12U
M*0G@X'J375#8DQ(NRSR;9756+/X(I8K/TOR #':!"2-&R9A'4:1#TI)  @@@
MY)%&*M0UM-53JL'U'EOSUY, +KQK=.E">;I]BM8\O/4?;VX.YH/# Y)PZM&&
MA:.O53$AEL4"4B2M09I3BD&K36%P_<?.>/PUPCBKJEOG_[4\=H8E'$"C*5:6
M2$R ))Q@'-S$@%L 0OW;1B2#:TAVS&9?2<3-;D.*NX?H^BJK\T.'AY>PQ'(,
M* (X@L 2$)LX\*$A";NAY.$<Q-M(87 MR);L]13Z*Y\V/XR]O%]=EX=*AV>8
M1(8-S&+-@=01D<WC>*HB*6!(>Q(Q*]H$?7!MQC;4]?QE-YO9,BT6[LB/&O9!
M$QZQL%U!'B,LPV85"0*H"@<AC)'1FJLV\1]<-[$#!GOM(IJ5\XL@T/_Z\JY>
MAE2U3HO[HVW$O2,2$;*6XL9*8@@1!HDHEH8C'?%0'T/8Z@=/ ^TC=D%DK]I0
M@0B?YF>A6-G\SQU7Q0ML8@F%0!E.E(*!%A0S 9D%2BED*&NGA\&U%KN@L"<E
MR%"USIO*U>;IXH "GF$2 K#0  B.!"61T-R@R(0<![6P$6.Z3>0'UUUL0]WW
MB+^;[K!V'FZ\?_/X0?/2_"/0^S?_!U!+ P04    "  M."=0,-E!6IX7  !^
MF   #P   &9O<FTX+6LQ-S(P+FAT;>U=6W/;QI)^/OD5L\R>E%,EDKA?:%FG
M<$V4V)*.)&]2^P8"0Q''(,  H"3NK]^> 4""Y PHR90M.4Z58Y,]UYZ^?-T]
M (__=3]+T"W.BSA+W_7$@=!#. VS*$YOWO4^7OM]H_>ODQ^._ZO?_].^?(_<
M+%S,<%HB)\=!B2-T%Y=3]$>$BT]HDF<S]$>6?XIO@WZ_ZC0?V9+E*+KN"(I@
MJ((M&J+JNZ;N6Z9E^J*F']V/@G$@B!,<A,984O 8!Y$TF1BR+$=:* 63<3/8
M>O:PGGU1P#KKZ=&JF9/-EWE\,RV1)$A"LZ2*/BUAO[#GM'C7FY;E?#0<WMW=
M#>[D09;?#$73-(?WI$VO:C0JPBF.LK@_P5&:E7C5:1(48]HEBHOA5J.A)(AF
M7Q#[LM@,,RGZ<5KB'!<E>XA6 T;W8C+OQ^-LMVM1SH8UD=.MZ.I6L+O%8;\H
MHU6W^W&># H<#FZRVV%-)-W$K6[E/._H5U.;/V0 8W. <)'G('S+/APQ?Z#M
M5HP-)#A@<QD(C.9A.4[8[0F%T>%F$>3L#H3"Z) OV,WS!8O]A%-!DG3P$:C-
M'P8?89<%=_\%1T["),<=DD+)C*YQD,7LN0B%-1?H29PRUD=GJHBL,\H6:9GO
M$XW-1F08G3E,9W=&-ZJ=!4>H:B)CT6D0AP5[+DIB+3#DV!@@L-B?WG*XG][R
M%M3-PXTFC 46^6;G]?GE/'6D(DM&[!;JND6'8*^:=5N9ND6'I6D,=AP'G$-M
MMV!L:5'T@SS,LP0S)+E%9'2-PG"><6:M:!RM*<8,36NT!HCL9=X$P7R#\>UE
M-D36C.&D7[".F4Q(:2PMQ6$2!DDH\^SIBLYB#(Z[I:35@-E]GN.0P((-STY'
M(/-+@F .ZW,9KAMOJ@9W[A69H1(Y1V5SEL82-2F7<Y;<K$@L#X*A!6^::GL,
MVQ R+'IM'4*6-=_PK5Q>;+?J&FB_&V?;C(TYX+0>L!)HQ1@HR#D\  *C.;X/
MI^RY"(71(0OG$XZWI:2.O77OB6N^]YANOMEF6H&:P'2Y43R)04D@-.C/@YR!
M7'>:L 6>.6NG"HL=.LQ18.!"GZ>)%8V+1E@+7*$1UD+Q[#\<OTLHK'E@ <5B
M/@_YZZ-DUEQ_+>)RR9F-TEBZ?\]CH"B#]B=QBDD\MUX>;UTLN0 ;.N;8=T)B
M[2'B62)"873@15K,X(KXA4ZGP99OP&UCAH.K(=V8997 ;D* QI]L3:><WNP\
MY?%@RF0!60,_6!RSQ!(\.A^2</$()Y2)6($,YEE3S+2F;4#.=R>;C5C&JP9C
M61;>=<,UTH*#2_B(A.5NYQS)  (3+%73%XO9-$LX7;<:=< GJ1L]22PW5$Z3
M.."H94WDV#]\,^/;/R!V[7>:Y>4#=MPT8Z^ .SM+6N,I#SL#A6D<>%I$*!U[
MV[\MSH[2Q8QM?*,R'Q)\-X06.(_#+:O"]>MK.L.JW(,M_\3/91'J=C2P'4'M
M1 3\S,J8X\#&+,]%4D7=8=^Z 2.?1 !7=[37;L&WUIU+V&S#X&\><K8,!);A
MX-D-INQ/YOU%V)EWH626(5YPTBY 8+M(KGMD@>8Y>_" A;")F<AQW &B")7E
MX=H:1B0WF,7AHBBG. _F>%$"FAV$&;$_@/M$06]YQEG&0I6U;R1$#@:#E;!R
M3VN,R,X^[>A8&Y'*0T(>!P5NSQ2FT23FN-8UG8F7.9U8C5<!T/Y@C1_F1]P4
M<45D@Y/)-.&XFYK(AHYS/G2<L[HT03_7"+0:L"$1)]IN*!RF,#-K#5/8V;6*
M$L4YPT.M>Q(ZR[(6V63",:Z$Q(E5NZU;NP4+-'!L2$?BMF-W*SJC,UE5W*%!
MH'9ED(9K#6KP7%E,.>K0:L$QK7RYKH@L >48>Z:M3[/T ;X>(N,M?P^B7HPY
M%K:B,8%/D<TYIJNB,;-&$TRT'W-97X?3JX:K-7)#?FZ@7Z,'+JS@),,X$<N*
MU!%6["T$L',A*2[W\0.:[&CU'J5FL3])>?$2);$"7\X1ERP^-'BM$\RQ[>(Z
MS;\GY<F/RD!FN&S4B$1M^)@N_K&Y1PQ[I]7G[(QCU%*F40-/S,<2#97E ./)
M+2]Y0$CL$ UT[)ZC^ V5XU=8F:V&?>S,%JS]]B_^OF[_XJ:I&.'@.DG%"@>I
MF^E&Z5T(O0N9,Q Y#U6QT=04A[P DY"8L#3D84N@,#TCPVM4+I$9%I'J21?D
M8E?EXS0L@WO.UBF-T6D^YR32@-!A6/?F:M@6(;X'&(;##:NP/LXFZ3@L\R M
M)ED^HWEC,H[:%XR-9:0<[U@UY\29G7<66A!1W%DUVX[M6[+4ES1&K+DOCF^M
M9$NRJTHR%U2S8Q/,0P68"0E(A93#): ,=VNE<7##JR(!A25S 2=;#03VZ7%/
MC7%:9<Q#)@V%%<^&F /L"*7#LV(B[1=9G'*J)^QV+*_$,2G,\D+!JA-0Z\"N
M$! #VQT#L!<51RSD18\V8@=&59VB,X:NZ!PU[4P%L=- ]PE;.VG<\.?[5GXK
MQS<9Q[M2$B=,"!/>;92*R+23G)1IE:Y@9TBZ\B/L6/D&\^P@I76%A-R2:;L%
M2T[QS9X2>HV/;]JU-\Q+1K'\*QDNVG+Z]>CJL"+V3G[XQ_$4!Q'\_8_C&2X#
M1%KW2;T+PG(G2TNRA6L(L'HHK#Z]ZY7XOAQ6E_>&M&,9EPD^:6X-'@^KSS#T
ML![[>)Q%RY/C*+Y%1;E,X(@F,%A_$LSB9#FZCF>X0&?X#EUFLR!]2VE%_']X
M) KS\BTLLMT3]CM/@B6)"G'OY#B^'Y%)<%[],XXBG-)_ OVLB@>KE=^7EP1(
MNR3+]6_1-WX7=4GHH328D4%Q/+)@\1'9@)\$-ST4P^'X05CV5=G0%,%P=-_3
M5-DQ+$'25567/%W655_3^G>?^@]JV$.59WO7 U<X&F=PP$$Z"9("]D'_.AYN
MK/MIV_!28/_2(98R2$[3"-__CI>M[9B"9EN"+(DVR($O298N@I>U-%^17=MQ
MG-5V]C7LG0@"6!'=,'3S("O_(X]+D# GF\T6:5WM+MH'H>B&ZUN.;XB*JNF:
M(0B.*%NN:6N:K#G6^B#V--PX"(*DZ&&,P2YFY3B[[YW\]*.I*\K;G5T--T5L
M%<T7)\<D-TG3*;, MHEH06 TI;$;R;_VF^3JX+X@ZDS))''QKE?$LWE"1'FX
M.48U77L.^K'(%CG]1',]HYJUE$M;K*6Z6;7"5"C(%\TWX'G@NTF,<T1GQ$PT
MZ9S^OGG,VYWI',/M2>HYYL"U+&K/6I0 '%PP:2=DJ<1>"7K3?4UK=0"5Y#1O
M**T%K.9KOJB9TW!RQ;IARVJ  ;VEINGD.*!<+&1-EUQ)T55#DU1=,6U%)\*D
M>B[H@NZXY*B"C8XM\T2@;'^*R;7HD2@)_]RU9L?%/$A9=C!.(32-2T:/<3Z$
M^4B_9MK6Y!6Q:QV2+/WS[3R(R&WS_C@KRVPV$N;W;PEO  W$-^DHQ.16]*I1
M@B?E2-:;-G%*#GPD*?!%:W7&D_9#/]Y5*QN#:L 0J-G<(X8RV$-]/#N]]EQT
M=6U=>U>;/.LZI7VL4+98T9<^EQ6<]5]YSL?+T^M3[PI99R[R_G1^M<Y^\9!S
M_N'#Z=75Z?G9X3:E[=G4T^25L:D_K*M?3\]^N3X_.T+NP!D@25 5\Q6>CG]^
M^6%#6+<]'3$@D2%KFBEB?0T-%$VQ *!YHN4*JBY:IF@HGJO;MN;HMNOX;3?8
MX*@6ZF*[3L:&.A=O]']?L7S;L1U*_="3#I6<XM:1&H<01:;I?$Y!DQZ]3(G-
M1S "E][9-;KT+LXOK]'%Q\NKCQ9\OCY_A9L!FW8-A@N),CJ_1*+Z)OH9G?OH
M^E?O=6ZF,= KXVPYUV1#HBDKKUO^MT""J#T )>SC_%.73M =RB;H$L^SO$1O
MFL\X &B'BQ+A6_*,6D[)./IY]!04P7%8Q[L#W4WC$O?AFQ"#Z;S+@WFOR_B;
M^MKXV[8MB[XB2+*A2I9BF(YFJK[K"Z;GNH+",OX7%,IZ%<;M] (;064$K6?0
M=AH%RR4P"J>]D]^"=!'D2Z0?T>?T>+9_\Z]'G]8C#'\C/F4V'QD'$+"6=^\Z
M$5&05D<"<:!K0:RNR8*L*HIDF9YNZH8N28[H" #Q=P+J2WP3%R0]79X!Y:!^
MV?IPZGR\(N;PTKKP/EZ?.E='Z/3,&;Q0;_U%K< ;[QX.#!&F5\:@.084%.AJ
MCD,2AD8H3M%I62!G"C$DSG]^Z1CYX,#D$<OLU!%1:>F(("BBZ)J:;*F>[EJ&
M*YN 6$5?-0R2_]G1D=,TS'*PQC1S<U6"+7*J.I:310\W8C0A4Y#>\SR[)7,0
M*[;+X4U1=G$2W('!.YS.[(M57[#.4-ZC+$?GI-J-?EOD<1'%(3D64**7OX$-
M0?HL9=Y=3*O_QF:$K;V0S^T)4B*AR8;S$DD;&+(,Q@E&(4Z2FOJN!R)-/A.X
MT'Q^?.9[%N0W<5HM+UB46?,%?>B^^N8NCLKI2*= ;9SE$<[[898DP;S H^8?
M.TB3+#F'/Q&H)%EB^JZGDJ16&9'_Y2MJ@WSH')*B5+NES;:I6@=-DLR#]&0L
M[1;G91P&2;V["K9N"BD1R?:AM3_7,+?]5<5;J9JV)2L/$:W'0]QMHU7E]C99
M\57V2.7D #O\Z4=1$]Z^O/T=[@SW^U157/E40=(%4HW0%5E5+=VR!%FP#5\6
M7%M51,/8]:E^G& 8=8SS;LPID-J?K)CZ/GS_8H[@NXA];GC:(7/:6N8\S7)M
MF10O'%M5)=,6=<O0#-^P75_717%7YJZ#^].ZPE-5X1XB@+K8AWC*E-6]$>;Z
MA%ZL17]TPI@38'4A,2ZLV4[",$/DPZ\5HJLNW/425&K+9#QIYZ_(8!Q,"DE)
M/2Z*%RATQ+VARKQ\E[=O1MY.!Y>#JP'R9O,D6^+\I0G=IG-#9]F )7O4.0UI
M;+=3=7]$!-J.*47S0 %R)5+/]__#AMR'Q]22H*[PC:3:BNY)GB]9@FHJBJ$(
MKB1IANFYGF&J]BZ^L:(HQT51__4>MB1V8QL1.3@*<F3G6?8)N7E\NWM7ZS/S
MYT=/K5X\B%OF^E:7)-NZ)EB>H%JJZ$B&JZB>*#J*KUB.K#.R>C6;'/CG>7Z=
MW:7=O'+R(!TO\N6K8I HKT,TV54<P3$UX(^JZHXA2)YIJZ[LNJ+E*@J7013J
MG><7>78;TR>\NKAT]MNA^?.L[%D7LU3;\57+-!1-DU7-T2S'LD'13%N2#5>7
M?2Y[+K*B#)+_C>=[D\$G@J&*TK/QY_-LVL%\9,T64M2XR$%@XGF0(.\>AXL2
MS LZGX!_PL41"M(( =<08=N!4Z%?OFCQ17R#M)96W95TQ[-UEVBS[\JFX+B&
MZONB;"B28ZEM:24&SLIQL%\^-6'WPNMG2F?_&;577N<"1,.75-=W;=<!SRBX
MAF$XNBR[JN4+DJ1H;7Z\SP"07DRS]$'Y)TV3^I(@[ O^7[O:KNN//_UH@%U\
M6Z!KG. Y85,=QQR1,#I9$&"+B#Q1S?W:2O.YBOLL*/:-G^4@)75Q-T?UQ]HR
M'J%X0@JZZ0V.T!5QJ>A]4)3U?9!MR/[:;MKL7]-S%-:<*0X_H7**43"?Y]D\
MCTEZ:IS=HS%.LCO"<4(D!X&,_N]H$B=$C.,"D;<FPUHB5&:HB&>+I Q2G"V*
M9(D*"*.*R9+VK#MD8]A94-<;*2%?%^X7,$X.?FW9T"99 I.3?J3B&Y,\13%Z
M.BN?YS /5N1#N[.QZFV:NE$8>W#&M,SFO6Y^;<V_6]+MX)@%$I.@CVD<@E%#
M'Z[V&NSN1 <L]NV>U3[#Z=8/FH _:S]I@N:+O%@0 041OUS 82N26@LKD=(K
M@&;0,8;#M,(2O1%UY/B72)*% 33<FT%XLC&@@M V!IJI/>ERAZ2MHQQ7%71)
MMUW3U@75]B4;8( @.[JERI[C&1M%@:LLB4/8>'KS :P%$8#'W>78>KCFX;+5
M>A#GD)<Z>B?K':%9O:7=TQ>5H"]*+0'P[D/JC3:/7Q$&5<M#.:2=\U;X'JKS
MN'5A==R&:AB2*1F"Z4FJ*,N&IBF>YFF"I:N.XVS@X(L<DWPQ>>:(7D,G9C^'
M<&0/ GP%QPX[ZX>MK>TU *(2]:4WXY\?)@15VY<G!NMPR#4<R30DD +5@4#>
ML4W+\CT18G=1<4S/[Q"#TZ)8X/QO+0PR[BMOPH<)0]WV$<*PE0LWMM+]6Q=E
M#^4*6TZM0F@X!XS7WCNTH#A.I(I0(S;8[], VM_K6I;PN=>RY/W7LF2YZP*5
MT'5I2]*>=+VJWM"Z:(,*\*<1^E&@_QVH;%7/0@?9G:.F5LVY9"H-.\0O<"GH
MFCP!7SVL$$Y1F 1%\83ZWW=&[V=T'M!$R]5R-LZ2-\53BLC?+)L/Y22:R_=4
MF''C\\ GW$UC^&;M.#[GBL_W4_C<1*_<*M/XNJ68IJ2:FJ*HAF>:MB?;DJBK
M@N6IIK<9WU488"E*8VJW]M3W ";!T5^56?@)700Y^I\@66#TW\) $ ]W]_";
ME88O6 B1I?4#3[H@V);H&H8M:>1=)*9@"[)BRK;B.)JG; 2 M4VM3&JW,/CG
M[]WOA_ZR#GUM!&39E$S7T71-\E5;M4Q=UDW;T!5!D%S+$UA&H EI]C[EMA/B
M$<?0/*US9EVYUK\?>1'TL7=MOD!X=)I&)"#$:+Q$(<V= ];_!'X/T^N<6XGM
MN$ P/D23)!RX03=Y=E=.25PY)\GNH$ 1GL FZ--J58)14)N(:BN["-^*IBRO
M@DIR+4=_2W.-@OHS*994,:DT[DN,(38"TVHL97LL$J:2[C\/$/(X:W[HJPYD
M>6UJ7$'0!=GW)=F655^53,]V%5%3'%_6'-O7=F\(-+/_0B=WJKE?>W[A:85+
M:G>^0CGJ$+HRZ9#^(Q2S52G>*0]-05%P@D/RPZ-I1G,0BP+35L"GN@A%WA,9
MT[Q$]=(?(A!TKF1))J<_ETH$.(4@'B@YOHT+Z ?J%Z0A$8$@I._8)(W)*[&C
M((^*JOP4\1(@\IM@E0!I*]A@[]6;_563;2$\X('MGYPM*ZOW(1' (*BJ(NFZ
MK1J6;BN^Z2J*J6NF:JBVN?T^)-::Z2N(GE#S),K=AR]SL"RC8C$#F5E^6?5X
M'2O??@W4UWLGU31?Y_%N<'^<X^!3/Y@ _AD%R5VP+(BX3/,'K/(+<O#QK]-Z
M\1+QHFX>,&[2G)9XA@P(&NM'8SSR-H_B6;?Q*@Y@^TG^[9>N/761YRG:>A/(
M$;+H#\&@Z]8OP=#;2P/PG2FXQQ!<80CK)Z':$?'1BR0H,QB!7$J<P6@3X"1@
M3G"B070;U)64@CICZ[K_BV6!WR_)Y1'R1N;Z1@@XH^JG9Y:TW04X;8PB<,]!
M@0?( B\^KV^&Q,0CDSN2.2:_J(PIP"[+@/PD!2*O<0?O'!"P.XW'<8E,<R#2
ME='K*LV33'53@-P /%9O4QQ\46CTV$OUNQ+Q:D3WZR^4];9#46+$AU_3\)G$
M\/DK-$KOCE>Z0P2XEN@'6D-=>3%&G;S9JUG\ PN$3US]UY>SOW5I4S7USRQM
M2GM+FV)G:5/1VJ7-%U9F^!H/A3=N\"P;O-C<Z]?@BXN+,(_GNX]<O^Q'T!L&
M!!N-(QS6CV>/Z#448B_>@DYE^8B>E.]O6D9<"<7;'JK>15U_-DU1U ?3<O84
M$TEPUHJ3P:.D[.N\4N+EL7 +B:,+"G,O*YC+X6U7COQQX?\7#ZR__9S EUY<
M.S^GB*;DJH(BZ+ZCNI)ARX(N*)HE&()JB;;^X/S<EO(=XA7A![/B!WNY)]\&
M]$ZN8)\!!+0878"</CG:$/8&&\_#MM[)12MO7:75_UK$>1U9/*Q,=,3*QT>+
M9(G"8$%RZ#0NK]ZZ2J898U3 +H&0I338'^-ID$Q(M$T&HNRM&Y X?)%"'SH<
MH,EIEL/BHP<&XR12>#&<_AXG/"A.T 3QV>,$R5 [X@19U)X2)SP'4LE@JDF2
MW=6_(?)<F:47C,0>O;_][\9]>5#^4'LGKWX>;2=MO]6C[G++]G*$T+ 8(B])
M<(JN!F"4"IR.<7[STL3@NXH_Z7;IZ/O1?HM'2Z^3CI SC?$$O<<W05*_UR*G
M:6ZG*=$03)KC,B!OC3G,W; 74FC_TN'J/YH/] ?W?CBF/]-W\O]02P$"% ,4
M    "  M."=0@1$:LG81  #T6P  $               @ $     97AH:6)I
M=#DY,3$W+FAT;5!+ 0(4 Q0    ( "TX)U ?S_3@5 ,   02   1
M      "  :01  !F;VQD+3(P,C P,3 W+GAS9%!+ 0(4 Q0    ( "TX)U"7
ME3/=00$  ( "   5              "  2<5  !F;VQD+3(P,C P,3 W7V-A
M;"YX;6Q02P$"% ,4    "  M."=0>Z>)Z:<!  #2!0  %0
M@ &;%@  9F]L9"TR,#(P,#$P-U]D968N>&UL4$L! A0#%     @ +3@G4+2[
MCN"$"P  &F8  !4              ( !=1@  &9O;&0M,C R,# Q,#=?;&%B
M+GAM;%!+ 0(4 Q0    ( "TX)U =0^B0FP8  !PU   5              "
M 2PD  !F;VQD+3(P,C P,3 W7W!R92YX;6Q02P$"% ,4    "  M."=0,-E!
M6IX7  !^F   #P              @ 'Z*@  9F]R;3@M:S$W,C N:'1M4$L%
3!@     '  < Q@$  ,5"      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "form8-k1720.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "calculationLink": {
     "local": [
      "fold-20200107_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "fold-20200107_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
      "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "form8-k1720.htm"
     ]
    },
    "labelLink": {
     "local": [
      "fold-20200107_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "fold-20200107_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "fold-20200107.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
      "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd",
      "http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd",
      "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 97,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "fold",
   "nsuri": "http://www.amicustherapeutics.com/20200107",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "form8-k1720.htm",
      "contextRef": "D2020Q1F8K1720",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001000 - Document - Cover Page",
     "role": "http://www.amicustherapeutics.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "form8-k1720.htm",
      "contextRef": "D2020Q1F8K1720",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of each class"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>form8-k1720_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="fold-20200107.xsd" xlink:type="simple"/>
    <context id="D2020Q1F8K1720">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178879</identifier>
        </entity>
        <period>
            <startDate>2020-01-07</startDate>
            <endDate>2020-01-07</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="D2020Q1F8K1720"
      id="Fact-5386408C7FE653C8A0275572E7375F66-wk-Fact-5386408C7FE653C8A0275572E7375F66">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="D2020Q1F8K1720"
      id="Fact-906BA0321B005F22A71015A6F43DBCCC-wk-Fact-906BA0321B005F22A71015A6F43DBCCC">0001178879</dei:EntityCentralIndexKey>
    <dei:WrittenCommunications
      contextRef="D2020Q1F8K1720"
      id="Fact-5478DFACF8145676800C13AD9B6636CA-wk-Fact-5478DFACF8145676800C13AD9B6636CA">false</dei:WrittenCommunications>
    <dei:DocumentType
      contextRef="D2020Q1F8K1720"
      id="d836691e76-wk-Fact-464A019E1AD0571A9184ED7BB6C7BDCF">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="D2020Q1F8K1720"
      id="d836691e97-wk-Fact-4BBB31F4023852A489C695FDF09EDD04">2020-01-07</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="D2020Q1F8K1720"
      id="d836691e102-wk-Fact-663DA40863035442A9E7978722C1C0CD">AMICUS THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="D2020Q1F8K1720"
      id="d836691e114-wk-Fact-6600411D963A5E7DA8D39BB61F588CCC">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="D2020Q1F8K1720"
      id="d836691e151-wk-Fact-0270800C74355A7AA030B8F30DB54188">001-33497</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="D2020Q1F8K1720"
      id="d836691e161-wk-Fact-E6ADB3ED21CB5529B17A868F8BDF7711">71-0869350</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="D2020Q1F8K1720"
      id="d836691e205-wk-Fact-25B47E2EF2A05944840D22689EDE895B">1 Cedar Brook Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="D2020Q1F8K1720"
      id="d836691e209-wk-Fact-923B760AE05A51C28D45E11C4F4AC37C">Cranbury</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="D2020Q1F8K1720"
      id="d836691e213-wk-Fact-03D4C0C965A5557C802E9B5D3DD1AD44">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="D2020Q1F8K1720"
      id="d836691e217-wk-Fact-5BCF5A98466356C6ACABEDE9B238D73F">08512</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="D2020Q1F8K1720"
      id="d836691e227-wk-Fact-7D27CEB7D65A5FD390CD85FF13842CA5">609</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="D2020Q1F8K1720"
      id="d836691e231-wk-Fact-18F25DFDBDC95B0D888C733D5AF02246">662-2000</dei:LocalPhoneNumber>
    <dei:SolicitingMaterial
      contextRef="D2020Q1F8K1720"
      id="d836691e263-wk-Fact-D50727BD9B705BF2BC7303C7A53ECE81">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="D2020Q1F8K1720"
      id="d836691e270-wk-Fact-8588292809E251338664E6E60A75CCC5">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="D2020Q1F8K1720"
      id="d836691e277-wk-Fact-D8C298209E5C5BCCB9AAFE1B2314C9EF">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="D2020Q1F8K1720"
      id="d836691e317-wk-Fact-F7A49925964458E99BE3B21750AE59E1">Common Stock Par Value $0.01</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="D2020Q1F8K1720"
      id="d836691e322-wk-Fact-700BA1D88B265F6690B03493B4CC6E45">FOLD</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="D2020Q1F8K1720"
      id="d836691e327-wk-Fact-33929DC6762F5B5A97379B874002DAE0">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="D2020Q1F8K1720"
      id="d836691e332-wk-Fact-D00703FF23B35F529EBD4164CF36CBF6">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
